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CHAPTER I 
 
Introduction1 
 
Preface 
Evolution of mammalian pregnancy is characterized by several novelties. For instance, 
approximately 200 million years ago, “proto” trophoblasts, or the cells of outer layer of the 
mammalian blastocyst that develops into fetal membranes, evolved in the ancestors of 
mammals (Chuong et al. 2013; Renfree and Shaw 2001)In addition, evolution of viviparity 
or live-bearing in occurred in therian mammals (Killian et al. 2001; Baker et al. 2004; 
Griffith and Wagner 2017), as well as, emergence of a novel organ - the placenta - in 
therian mammals and further elaboration in eutherian mammals. Eutherian mammals are 
further distinguished from other groups of mammals by the occurrence of direct maternal-
fetal contact early on in pregnancy (Griffith et al. 2017). This contact is further 
exaggerated in mammals that form invasive placentas (i.e., hemochorial mammals), such 
as rodents and primates, in which a population of trophoblasts invade into the maternal 
decidua (Carter and Enders 2004; Robbins and Bakardjiev 2012; Furukawa et al. 2014). 
Such formation of the invasive placentas in some eutherian mammals likely required 
novel mechanisms by which to regulate the extent of trophoblast invasion into the 
																																																						
1 The Contributing authors are: Jiyun M. Moon, John A. Capra, Patrick Abbot, and Antonis 
Rokas.  
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maternal decidua, as both excessive and insufficient invasion are associated with adverse 
pregnancy outcomes (Hiby et al. 2004; Hiby et al. 2010; Hiby et al. 2014).  
 
Mammalian pregnancy entails co-existence of a genetically distinct entity (i.e., the fetus) 
within the mother, and therefore, is an intrinsically immunological process. The relatively 
extended gestational period, as well as direct maternal-fetal contact starting early in 
gestation creates an even more difficult challenge to eutherian mothers (Griffith et al. 
2017) - to sustain a genetically distinct fetus without inducing an immunological reaction 
and at the same time, maintain optimal host defense against pathogens. Therefore, it is 
reasonable to assume that some of the novel mechanisms that enabled successful 
establishment of pregnancy in eutherian mammals involves immune modulation (Griffith 
et al. 2017). In this regard, while it was previously believed that the maternal immune 
system experiences global suppression to prevent immunological rejection of the fetus 
(Billington 2003), recent studies have shown that distinct aspects of the maternal immune 
system are differentially regulated both spatially (i.e., locally versus systematically) 
(Veenstra van Nieuwenhoven et al. 2003; Svensson-Arvelund et al. 2013) and temporally 
(i.e., in different trimesters) (Luppi 2003; Somerset et al. 2004; Germain et al. 2007; 
Bartmann et al. 2013; Aghaeepour et al. 2017), resulting in a functionally active, yet 
carefully regulated immune system throughout the duration of pregnancy.  
 
In this review, we will discuss the evolution of mammalian, and more specifically, 
eutherian pregnancy. We will first briefly discuss what sets apart eutherian pregnancy by 
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drawing comparisons with pregnancy in a closely related lineage, marsupials. We will 
follow this up with a short summary describing the diversity that exists within eutherians. 
Next, we will outline the global mechanisms underlying the evolutionary innovations that 
occurred with the emergence of eutherian mammals. Next, we focus on the evolution of 
two immunity gene families in particular: killer immunoglobulin-like receptors (KIRs) and 
sialic-acid binding immunoglobulin-like lectins (SIGLECs). We will briefly discuss the 
global processes that led to the emergence of these two gene families and conclude with 
the discussion of how differential advantages in terms of reproductive success and host 
defense activities have likely influenced their patterns of genetic variation in modern 
humans. In short, based on this evidence, we emphasize the importance of regulatory re-
wiring, and birth of novel genes that function in immune modulation in evolution of 
eutherian pregnancy.  
 
Overview of pregnancy in eutherian mammals 
While both marsupials and eutherians are viviparous, several major differences exist. 
Marsupial pregnancies are generally shorter than eutherian pregnancies (mean of 25 
days versus 131 days) (Bainbridge 2000; Renfree and Shaw 2001), and for the bulk of 
the gestational period, the embryo is separated from the maternal uterine epithelial cells 
by a thick but permeable egg shell (Figure 1.1a): during this period, there is no direct 
maternal-fetal contact, and the developing embryo receives nutrients from uterine 
secretions (Zeller and Freyer 2001; Freyer et al. 2002; Griffith et al. 2017). This egg shell 
is only breached shortly before labor, followed by apposition and attachment of the 
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embryo and formation of a short-lived yolk sac placenta (Figure 1.1a) (Selwood 2000; 
Griffith et al. 2017). In contrast, eutherian pregnancy involves a prolonged contact 
between the mother and the fetus, beginning at implantation that occurs early on in 
pregnancy (Figure 1.1b): the embryo is apposed to the uterine wall, which subsequently 
attaches, and in some species, invades, the uterus (Enders and Schlafke 1975; Cross et 
al. 1994). This is followed by the formation of the placenta (Figure 1.b), which serves 
nutritive and immune-modulatory roles for the remainder of pregnancy. It has been 
recently found that conserved sets of inflammatory markers and immune pathways are 
involved in both eutherian implantation and marsupial attachment and labor (Griffith et al. 
2017; Hansen et al. 2017) In contrast to marsupials, eutherians experience major 
switches in the overall activities of the immune system in the uterus during pregnancy: 
the up-regulation of inflammation in the uterus during implantation is followed by an 
extended anti-inflammatory period (Figure 1.b) (Mor et al. 2011; 2017; Griffith et al. 2017) 
which likely stems from the need to protect the developing fetus from detrimental immune 
responses. Towards the end of pregnancy, the eutherian uterus experiences a spike in 
inflammation yet again, resulting in initiation of labor (Mor et al. 2011; Leimert et al. 2018). 
Therefore, mechanisms to regulate the immune system in the uterus was likely required 
for establishing prolonged pregnancies in eutherians (Chavan et al. 2017). In this regard, 
it has been hypothesized that the absence of such immune-modulation mechanisms (due 
to the lack of alternation of the immune system during pregnancy) in marsupials has 
prevented longer gestation periods in this lineage (Hansen et al. 2017). 
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Figure 1.1. Comparison of pregnancy in eutherians and marsupials. A schematic 
illustration of the differences in the pregnancy between two lineages of mammals. a) 
Marsupial pregnancy is relatively short (mean gestation length of 25 days), and for the 
majority of the gestational period, the fetus is separated from maternal tissues by a shell 
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coat. This shell coat is only breached shortly before the initiation of labor, and is 
accompanied the formation of a transient yolk sac placenta. Formation of the placenta is 
associated with a spike in inflammation, which persists until labor. b) In contrast, eutherian 
mammals exhibit longer periods of pregnancy (mean gestation length of 131 days). 
Implantation and subsequent placentation occur relatively early on in pregnancy, 
establishing direct maternal-fetal contact that lasts for the remainder of pregnancy. 
Eutherian pregnancy is further distinguished from marsupial pregnancy in the occurrence 
of immune modulation throughout the entire gestational period: after the pro-inflammatory 
state following implantation, the immune state switches to a prolonged anti-inflammatory 
state, likely allowing optimal growth of the fetus. Towards the end of pregnancy, there is 
another surge in inflammation, which likely leads to initiation of labor. 
 
In order to support extended growth of the fetus, the uterus in eutherians undergo several 
changes to create a receptive environment. Most noteworthy of these changes involve 
the transformation of the endometrial stromal fibroblasts (ESFs) into plump, secretory 
cells, or decidualized stromal cells (DSCs) that produce cytokines, growth factors and 
extracellular matrix proteins in response to “pregnancy signals” (e.g., progesterone, 
cAMP, and in some species, fetal signals) (Gellersen and Brosens 2003; Gellersen et al. 
2007). Other changes include vascular remodeling to form spiral arteries that can supply 
large amounts of blood and oxygen to the fetus (Craven et al. 1998) and recruitment of 
immune cells to the site of maternal-fetal contact to engage in immune modulation 
required for preventing rejection of the genetically distinct fetus.  
 
Furthermore, extensive variation exists in terms of the nature of pregnancies even within 
eutherians. Eutherian placentas have diversified from the ancestral invasive placenta 
(i.e., hemochorial placenta) (Wildman et al. 2006; Elliot and Crespi 2009), resulting in 
three major modes of placentation, differentiated by the extent of invasiveness of the 
placenta (Mess and Carter 2007). The most invasive, hemochorial placentation, results 
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in invasion of the fetal trophoblast into the uterus and erosion of all maternal tissue layers, 
leading to direct contact between the fetus and the maternal blood (Furukawa et al. 2014). 
This mode of placentation is observed in rodents and in some primates, including humans 
(Carter and Enders 2004; Carter et al. 2015). Endothelichorial placentation involves 
invasion of the trophoblast into the uterus but without direct contact with the maternal 
circulation. Endothelichorial placentation is seen in groups such as canines and bats 
(Carter and Enders 2004; Enders and Carter 2012). The least invasive is the 
epitheliochorial placentation, in which the trophoblast is in superficial contact with the 
uterine epithelium without any invasion or destruction of maternal tissues (Furukawa et 
al. 2014). Ruminants such as cows and sheep exhibit this form of placentation (Carter 
and Enders 2004). Given this diversity, it is likely that different groups of eutherian 
mammals are characterized by lineage-specific adaptations that result from modifications 
of the global innovations that occurred with the emergence of eutherians. Furthermore, it 
is reasonable to hypothesize that hemochorial mammals would have acquired additional 
mechanisms by which to carefully regulate the extent of placentation to prevent both 
excessive and insufficient placental invasion.   
 
Numerous studies have focused on understanding the molecular mechanisms that 
underlie the evolution of pregnancy in mammals, identifying three major trends. First, 
extensive re-wiring of regulatory networks involving pre-existing genes have happened to 
enable appropriate transcriptional responses (Figure 1.2a-b). Second, birth of novel 
genes that serve purposes specific to pregnancy in eutherian mammals have occurred in 
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this lineage (Figure 1.2c-d). Third, species-specific changes as well as population-specific 
adaptations on top of such general and global changes within eutherian mammals have 
likely resulted in diverse strategies of pregnancies within eutherian mammals.  
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Figure 1.2. Molecular mechanisms underlying evolution of eutherian pregnancy. A 
schematic illustration of the proposed molecular mechanisms that have contributed to the 
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evolution of eutherian pregnancy. According to Knox and Baker (Knox and Baker 2008), 
genes of different function and evolutionary age are involved in the early and late 
placental development process, respectively. More specifically, ancient genes with 
functions involved in metabolism and growth have been co-opted to act in early 
development of the placenta. One mechanism by which pre-existing ancient genes have 
been co-opted to participate in reproductive processes could be recruitment of such 
genes into expression within reproductive tissues. This could have been facilitated by a) 
contribution of regulatory regions by transposable elements (TEs) as well as b) 
retroviruses.  In contrast, evolutionarily younger (often species-specific) genes associated 
with pregnancy-specific processes participate in the later developments of the placenta. 
c) Duplication events followed by subsequent species-specific expansions and d) co-
option of retroviral genes could have contributed to the emergence of novel genes 
involved in pregnancy. 
 
Regulatory evolution within eutherian mammals 
Emergence of novel phenotypes could be facilitated by changes in gene regulation, and 
several studies have shown this to be the case for eutherian pregnancy as well. For 
instance, genes highly expressed in the developing placenta of mice are enriched for 
ancient genes (i.e., genes sharing orthologs with eukaryotic organisms) (Knox and Baker 
2008). These ancient genes are enriched for roles in growth and metabolic processes, 
which is in contrast to enrichment of functions more specific to pregnancy/reproductive 
processes and negative regulation of physiological and cellular processes among genes 
highly expressed in the mature placenta, which are often rodent-specific (Figure 1.2) 
(Knox and Baker 2008). Such ancient, pre-existing genes could have been co-opted for 
usage in pregnancy by re-wiring of regulatory networks and some studies have provided 
evidence that such changes in gene regulation could underlie the extensive differences 
we see in marsupial and eutherian pregnancies.  
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For example, eutherian DSCs were likely formed by reprogramming of the pregnancy-
related stress response in marsupial (grey short-tailed opossum) ESFs (Erkenbrack et al. 
2018). Interestingly, when stimulated with decidualization signals (i.e., progesterone and 
cAMP), several core regulatory genes known to be involved in eutherian decidualization 
are also up-regulated in opossum ESFs, some of which were transcription factors (TFs) 
with well-known roles in decidualization: these include PGR, CEBPB, HOXA11 and 
STAT3. However, some TFs that are up-regulated in human DSCs (i.e., PRL, IGFBP1) 
are eutherian-specific and are not found in the opossum ESF, suggesting that recruitment 
of new TFs contributed to evolution of DSC. Subsequent functional enrichment analyses 
revealed that genes up-regulated in the opossum were enriched for stress responses and 
apoptosis, indicating that the decidualization signals trigger a different biological process 
in marsupials compared to eutherians. Interestingly, FOXO1, a TF that is up-regulated in 
opossum ESF upon stimulation with decidualization signals, regulates different sets of 
genes in human DSC and opossum ESF, suggesting that decidualization in eutherians 
evolved through co-option of the marsupial stress pathway by rewiring downstream 
targets genes of the highly conserved regulatory network.   
 
In addition, striking differences exist in the reconstructed ancestral transcriptomes of 
ESFs of eutherian mammals and transcriptomes of ESFs of opossums (Kin et al. 2016): 
more specifically, genes that gained uterine expression in eutherian mammals were 
enriched for functions involved in cell division and proliferation, while genes with 
expression in opossum ESFs but not in ancestral eutherians were enriched for 
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inflammation, cell movement and adhesion processes. Other examples include Siglec-5, 
6 and 14, which gained placental expression only in humans (Brinkman-Van der Linden 
et al. 2007; Ali et al. 2014). While the mechanism by which Siglec-5 and 14 gained 
expression in the human placenta remains unknown, one study suggests that Siglec-6 
likely gained human-specific placental expression via changes in the 5’ UTR region 
(Brinkman-Van der Linden et al. 2007): these include loss of GATA-binding site and gain 
of E-box and Oct-1 sites. More recently, extensive differences in species-specific TFs 
exist between mice and humans, possibly accounting for the large differences that exist 
between these two species in terms of placental development (Soncin et al. 2018). For 
instance, VGLL1, a potential human-specific regulator of trophoblast differentiation of 
embryonic stem cells, is not detected in mouse placenta at any point in pregnancy.  
 
More broadly, the evolution of eutherian pregnancy is associated with loss and, more 
interestingly, gain of uterine expression of numerous genes (Lynch et al. 2015). These 
genes are often involved in regulation of immune responses, metabolic processes, and 
cell divisions and this may stem from the need for carefully regulating such processes in 
the uterine environment during the prolonged gestational periods. We will discuss two 
mechanisms that have contributed to regulatory evolution within eutherian mammals 
(Figure 1.2a-b). The first mechanism by which these genes have gained novel uterine 
expression may involve transposable elements (TEs), DNA sequences that can “jump” to 
new sites within genomes (Figure 1.2a). For instance, a significant proportion of genes 
that undergo changes in gene expression upon decidualization are in proximity to MER20, 
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a hAT-Charlie family DNA transposon (Lynch et al.). In addition, MER20s are able to bind 
to TFs important for hormone responsiveness and pregnancy, such as PGR, FOXO1A 
and HOXA11, and other more general TFs such as CTCF, p53 and p300 (Lynch et al.). 
In addition, depending on the combination of bound TFs, such MER20s can act as either 
insulators or cis-regulatory elements (i.e., enhancers, repressors). Similarly, the proximal 
part of an alternative prolactin (PRL) that results in extrapituitary expression occurs within 
MER20 and another long terminal repeat (LTR), MER39 (Gerlo et al. 2006). More broadly, 
locations of regulatory elements active in DSCs often overlap with ancient mammalian 
TEs (AncMam-TEs) and genes associated with regulatory regions derived from such TEs 
exhibit significant changes in expression levels upon decidualization, which is especially 
true for genes that have evolved novel uterine expression (Lynch et al. 2015). In addition, 
these AncMam-TEs are enriched for binding sites for TFs with roles in pregnancy, such 
as those that mediate hormone responses (e.g., PGR, NR4A1, ERRA) or have functions 
in endometrial cells or immune regulation (e.g., ELK4, ARNT, c-Myc, E2F1) (Lynch et al. 
2015). In short, TEs have provided novel regulatory elements in eutherian mammals to 
enable appropriate transcriptional response to decidualization. 
 
Another source of regulatory evolution involves endogenous retroviruses (ERVs), 
retroviruses that infected and have been integrated into the genomes of host germline 
cells and passed onto the next generation. A typical ERV consists of three core retroviral 
genes (env, gag, pol), which are flanked by LTRs (Chuong 2013). While ERV LTRs 
normally function to promote transcription of the viral genome, it has been hypothesized 
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that they could also act as novel promoters or enhancers for nearby genes if they contain 
appropriate binding sites for trophoblast-specific TFs (Figure 1.2b) (Chuong 2013). Such 
LTR-derived regulatory elements could potentially co-opt entire gene regulatory 
networks, resulting in extensive changes in the placental transcriptome. While less 
investigated than the co-option of ERV genes (which will be discussed in the following 
sections), some studies have uncovered instances of LTR-derived regulatory elements. 
For example, a recently discovered anthropoid primate-specific LTR-derived THE1B 
element regulates expression of corticotropin-releasing hormone (CRH), a hormone that 
is involved in controlling gestation lengths in humans, and other placental genes (Dunn-
Fletcher et al. 2018). This THE1B element was also found to bind to DLX3, a TF that 
contributes to trophoblast differentiation. Another example involves a recently discovered 
novel trophoblast-specific enhancer that is required for expression of HLA-G in human 
extravillous trophoblasts (EVTs), which lies within a LTR region associated with ERV1 
(Ferreira et al. 2016). Similar to the THE1B element described above, this enhancer 
exhibits binding activities for CEBP (CEBPB) and GATA family TFs (GATA2, GATA3) that 
are highly expressed in the placenta. Other examples of ERV-driven regulatory evolution 
include leptin (Bi et al. 1997), pleiotropin (Schulte et al. 1996), endothelin B receptor 
(EBR) (Medstrand et al. 2001; Landry and Mager 2003), Midline 1 gene (MID1) (Landry 
and Mager 2002), which have gained placental expression via LTR-derived promoters.   
 
In summary, novel regulatory elements arising from TEs and LTRs of ERVs could have 
facilitated the recruitment of gene expression in reproductive tissues- uterus and 
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trophoblast, respectively- resulting in appropriate transcriptional responses to promote 
successful pregnancy.  
 
Emergence of novel genes in eutherian mammals 
As discussed above, eutherian pregnancy involves activities of both pre-existing genes 
that were originally involved in other biological processes (Figure 1.2a-b), as well as 
novel, evolutionarily young genes (Figure 1.2c-d) (Knox and Baker 2008). For instance, 
a large-scale classification of proteins on the basis of sequence similarity has identified 
numerous genes that have emerged in the stem lineage of eutherian mammals and have 
either been conserved in all species or lost across different subgroups of eutherian 
mammals (Dunwell et al. 2017). Subsequent functional enrichment analyses revealed 
that these genes are often involved in immune responses, development, and regulation 
of transcription.  Two mechanisms- gene duplication (Figure 1.2c) and co-option of ERV 
genes (Figure 1.2d)- could result in emergence of novel genes in eutherians. 
 
Several phylogenetic analyses suggest gene duplication, which is followed by species-
specific expansion or contraction events, to have played a role in emergence of several 
novel gene families (Figure 1.2c), including pregnancy-specific glycoproteins (PSGs), 
KIRs, and SIGLECs. Part of the carcinoembryonic antigen (CEA) family, PSGs are the 
most abundant secreted trophoblast-specific proteins detected in the maternal blood 
during pregnancy and may play roles in modulating the maternal immune responses. 
These include inducing monocytes and dendritic cells to produce anti-inflammatory 
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cytokines(Wessells et al. 2000; Blois et al. 2012; Martínez et al. 2012), promotion of 
alternative macrophage activation that results in suppression of T cell activation and 
proliferation (Motrán et al. 2002). To date, PSGs have been found exclusively in 
hemochorial mammals (e.g., humans, rodents, and some primates) or mammals that 
possess a population of trophoblasts with invasive properties (e.g., horses) (Kammerer 
and Zimmermann 2010). Phylogenetic studies have shown that PSGs have likely risen 
from duplication of an ancestral CECAM (CECAM1) gene, followed by additional 
subsequent expansion events (Kammerer and Zimmermann 2010). In primates, PSGs 
have undergone a major expansion after the separation of wet-nosed and dry-nosed 
primates, followed by independent expansion events in apes and rhesus macaques 
(Chang et al. 2013), respectively. 
 
Another example involves KIRs, a family of genes that is part of the leukocyte receptor 
complex (LRC) on chromosome 19 in humans (Parham 2005). KIRs are expressed on 
uterine natural killer cells (uNKs) that come into contact with EVTs invading into the 
decidua (Moffett and Colucci 2014).  The interaction between uNK cells and EVTs 
regulates the degree of trophoblast invasion into the decidua and subsequent remodeling 
of the spiral arteries (Lash 2006; Fraser et al. 2015). A subset of KIRs expressed on uNK 
cells binds to human leukocyte antigen (HLA) type C on the EVTs (Varla-Leftherioti 2004; 
Male et al. 2011): this KIR-HLA-C interaction results in the activation of uNK cells, leading 
to secretion of cytokines and angiogenic factors that facilitate placentation (Xiong et al. 
2013). Duplication event of an ancestral KIR gene that occurred approximately 140 million 
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years ago resulted in two founder KIR genes: KIR3DX for cattle and KIR3DL for simian-
primates (Guethlein et al. 2007). During the past 40 - 58 million years of simian-primate 
evolution, KIR genes have expanded from the single KIR3DL gene (Sambrook et al. 2006; 
Guethlein et al. 2007). For instance, a subset of KIRs that can bind to MHC-C (HLA-C in 
humans) first expanded in orangutans (Guethlein et al. 2007), followed by additional 
species-specific expansions in chimpanzees and humans (Abi-Rached et al. 2010). In 
contrast, KIRs have experienced intensive deletion and mutations in gibbons, resulting in 
contraction of the KIR locus (Abi-Rached et al. 2010).  
 
A similar scenario unfolded in Siglecs, immunoglobulin-like lectins expressed on immune 
cells that bind sialic acids ubiquitously found on host cells. Some genes belonging to the 
subgroup CD33r-related (CD33r) Siglecs exhibit expression in reproductive tissues 
(Brinkman-Van der Linden et al. 2007; Ali et al. 2014): While the exact role other CD33r 
Siglecs play in pregnancy is less well known, one mechanism may involve regulation of 
the peripheral maternal immune system during pregnancy, as discussed in more detail in 
the following sections.  In mammals, the primordial CD33r Siglecs cluster (which formed 
via tandem duplications of the ancient Siglecs cluster) has been shown to have 
undergone a large-scale inverse gene duplication event approximately 180 million years 
ago (i.e., before the eutherian/marsupial split), followed by species-specific expansions 
and contraction events (Cao et al. 2009): for instance, while the early post-duplication 
cluster underwent additional duplication events in primates and dogs, this cluster 
experienced significant contraction in rodents.  
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Other examples of pregnancy-related genes arising from gene duplications include 
hormones such as growth hormones (GH) in primates (Chen et al. 1989; González et al. 
2006; Wallis and Wallis 2006; Mendoza et al.), prolactins (PRLs) in rodents (Li and Zhang 
2006), and chorionic gonadotropin (CG) subunit genes (Maston and Ruvolo 2002; Fortna 
et al. 2004).  Additional examples consist of the homeodomain-containing TFs or HOX 
genes, that are known to play important roles in pregnancy (Ruddle et al. 1997; 
Soshnikova et al. 2013); galectins, a highly conserved family of b-galactosidase binding 
lectins expressed on immune cells (Houzelstein et al. 2004; Than et al. 2009); and 
placentally-expressed cathepsins (PECs) in rodents (Sol-Church et al. 2002). In all cases, 
there is considerable diversity in the repertoire of such gene families among species, 
resulting from species-specific expansion/contract events that occurred after major 
duplication event of a single ancestral gene. In this regard, it is interesting to note that 
Knox and Baker also found that the majority of the rodent-specific genes highly expressed 
in the mature placenta are members of three gene families that experienced major rodent 
or mouse-specific expansions: PRLs, PSGs/CECAMs and mouse PECs (Knox and Baker 
2008).  
 
A rather unusual mechanism by which novel genes potentially arose in eutherian 
mammals involves genes of the ERVs (Figure 1.2d). While most of the ERV genes no 
longer code for functional proteins due to accumulation of mutations and deletions, some 
proteins have been retained to serve important functions for their hosts. Syncytins-1 (Syn-
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1) and 2 (Syn-2), envelope genes of HERV-W (Mi et al. 2000) and HERV-FRD (Vargas 
et al. 2009), respectively, are such genes. Early experimental works have elucidated 
direct role of these genes in mediating the fusion of the mononucleate cytotrophoblasts 
to form the multinucleate syncytiotrophoblasts (SYNs), the outer layer of trophoblasts that 
comes into direct contact with maternal blood and involved in maternal-fetal exchange 
(Mi et al. 2000). Furthermore, reduced expression of syncytins has been shown to be 
associated with adverse outcomes of pregnancy, such as pre-eclampsia in humans and 
embryonic lethality in mice (Chen et al. 2008; Dupressoir et al. 2009). Furthermore, ERV 
env genes have been integrated and co-opted independently in multiple lineages 
throughout mammalian evolution (Lavialle et al. 2013). In addition to its involvement in 
formation of the SYN, Syn-1 may also play a role in suppressing detrimental antiviral 
immune responses, thereby creating an immunologically tolerant environment for the 
fetus (Tolosa et al. 2015): Syn-1 treated immune cells from non-pregnant women 
exhibited reduced production of interferons (e.g., IFN-l, IFN-a), whereas levels of the 
anti-inflammatory cytokines (e.g., IL-10) were increased, and changes in levels of such 
cytokines were similar to those seen in pregnant women without Syn-1 treatment (Tolosa 
et al. 2015).  
 
Apart from syncytins, genome-wide searches for ERV Env proteins have uncovered 45 
Env-encoding ORFs, one of them encoding an unusual Env protein, HEMO of the MER34 
family, which is missing several characteristics that are shared among other Env proteins 
(Heidmann et al. 2017). Unlike other Env proteins, HEMO does not possess fusogenic 
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properties and is shed into the local and peripheral blood in pregnant women. While the 
exact role of HEMO in pregnancy is yet unknown, it is speculated that the shed HEMO 
proteins may act to sequester receptors that could be used by other retroviruses, thereby 
aiding host defense activities (Heidmann et al. 2017). While the exact roles in 
reproduction are yet unknown, there are other examples of ERV-derived genes (and 
proteins) expressed in the placenta. These include the transmembrane protein (TM; 
resulting from cleavage of the Env in the Golgi) of HERV-K (Kämmerer et al. 2011), env 
gene of HERV-E (Yi and Kim 2007) and env-3 (Andersson et al. 2005; Mangeney et al. 
2007). These ERV-derived elements are hypothesized to play immunosuppressive roles 
via their immunosuppressive domain (ISD).  
 
In summary, the evolution of eutherian pregnancy was likely facilitated by both co-option 
of pre-existing ancient genes to promote early growth of the placenta and the emergence 
of novel evolutionarily younger (often species-specific) genes via gene duplication and/or 
ERV-co-option events, which act in later stages of placental development to regulate 
more pregnancy-specific processes. 
 
Trade-offs between reproductive processes and host defense have influenced the 
patterns of genetic variation of genes involved in pregnancy within humans 
 
Prolonged direct maternal-fetal contact in eutherian pregnancy (and in some species, 
exposure of the fetus to the maternal circulation) likely requires careful regulation of the 
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maternal immune responses to prevent immunological rejection of the fetus. This refined 
immune-regulation must occur while maintaining efficient host defense abilities and it is 
commonly believed that the resulting selective pressures on these processes can be 
conflicting. For this discussion, we will focus on two families of immunity-related genes- 
KIRs and Siglecs (Figure 1.3) - that have been found to play roles in both reproduction 
and host defense. 
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Figure 1.3. Examples of trade-offs between reproductive processes and host defense: KIRs and Siglecs. A summary 
of the key features of two gene families that have been shown to play roles in both reproduction and host defense. This 
figure illustrates what is known about the a) general structure of the gene and repertoire of the gene families b) the 
evolutionary process by which these gene families have emerged c) their known (and in the case of CD33r Siglecs, 
predicted) roles in pregnancy and d) trade-offs between pregnancy and immune activities. 
1) KIRs
a) Structure and gene repertoire b) Evolution of gene family c) Role in pregnancy d) Trade-offs: host defense vs pregnancy
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KIR haplotypes can be divided into two functionally distinct groups – A and B – which are 
found only within humans. KIR A haplotypes are characterized by fixed gene content 
which mostly consists of inhibitory receptors with strong binding affinity (Figure 1.3) (Abi-
Rached et al. 2010). The inhibitory KIR A haplotype, due to insufficient placental growth 
resulting from suppressed uNK activities, is associated with lower birth weight and 
adverse pregnancy outcomes such as pre-eclampsia, especially in combination with fetal 
HLA-C with the C2 epitope of paternal origin (Hiby et al. 2004; Hiby et al. 2010; Hiby et 
al. 2014; Farrell et al. 2014; Nakimuli et al. 2015).  Interestingly, KIR A haplotypes are 
associated with more effective host defenses against acute viral infections such as Ebola 
and Hepatitis than B haplotypes (Khakoo et al. 2004; Wauquier et al. 2010), likely due to 
the attenuated KIRs of the B haplotypes and increased polymorphism of the KIR A 
haplotypes (Figure 1.3).  In contrast, KIR B haplotypes are more variable in gene content 
and consist of less polymorphic and attenuated KIRs, some of which are activatory (Abi-
Rached, Moesta, et al. 2010). Contrary to KIR A haplotypes, combination of maternal KIR 
B haplotype with fetal HLA-C1 is associated with the lowest risk for pre-eclampsia (Hiby 
et al. 2010; Nakimuli et al. 2015). KIR B haplotypes are also associated with KIRs that 
exhibit attenuated activities or even lost binding affinity for MHC-C ligands (Abi-Rached 
et al. 2010), and therefore, are likely to confer weaker host defense against pathogens 
(Figure 1.3). Frequencies of the KIR haplotypes, individual KIR genes, as well as diversity 
and identify of profiles of KIR haplotypes, vary among human populations (Nakimuli et al. 
2013): for example, there are more KIR haplotype profiles in Ugandans than in the 
Europeans, homozygosity for the KIR A haplotype being the most common in Ugandans. 
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In addition, the frequency of HLA-C2 epitope is higher in Ugandans (and other sub-
Saharan Africans) compared to elsewhere in the world, likely because of its protective 
role against pathogens such as malaria. Furthermore, KIR2DS5, which is present in 
higher frequencies in Ugandans compared to Europeans, confers protection against pre-
eclampsia only in Ugandans when present in the centromeric region of KIR B haplotypes 
(Hiby et al. 2010; Nakimuli et al. 2015).  In contrast, KIR2DS1, which is the protective 
gene in Europeans and not in Ugandans (Nakimuli et al. 2015), is present in higher 
frequencies in Europeans (Nakimuli et al. 2013). More broadly, it has been suggested 
that within a population, the frequencies of the KIR haplotypes (and HLA-C epitopes) 
fluctuate over time in response to changing selective pressures (Parham and Moffett 
2013): for example, emergence of a novel pathogen might result in higher frequencies of 
KIR A haplotypes (and HLA-C1 epitope) but following successful eradication of the 
pathogen, increased selective pressures on reproduction could result in increase in 
frequencies of KIR B haplotypes (and HLA-C2 epitope) (Parham and Moffett 2013). In 
this regard, it is interesting to note that the risk of pre-eclampsia is high among sub-
Saharan Africans (Nakimuli and Moffett 2017), which is likely due to the high frequencies 
of KIR A haplotypes and HLA-C2 epitope (Nakimuli et al. 2013). In summary, patterns of 
genetic variation of KIRs within any population reflect the actions of selection on both 
well-regulated extent of placentation and optimal host defense against pathogens.  
 
Some CD33r Siglecs occur as paired receptors - receptors with binding affinity to almost 
identical ligands but with opposing signaling motifs (Figure 1.3). Siglec-5 and Siglec-14 
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are such paired receptors: Siglec-5, via the immunoreceptor tyrosine-based inhibitory 
motif (ITIM) on its cytoplasmic tail, acts as an inhibitory receptor, while Siglec-14 
associates with the immunoreceptor tyrosine-based activation motif (ITAM)- bearing 
adaptor DAP12 and therefore acts as an activating receptor (Angata et al. 2006). 
Interestingly, some individuals lack a functional Siglec-14 (Yamanaka et al. 2009): this is 
due to fusion between Siglec-5 and 14 into a single gene (Siglec14/5) that is under the 
control of the Siglec-14 promoter but is functionally equivalent to Siglec-5 (Yamanaka et 
al. 2009). Interestingly, such Siglec-14 null allele in infants is associated with incidences 
of preterm birth only in the context of maternal Group B Streptococcus (GBS) rectovaginal 
colonization, speculated to be associated with an suppressed innate immune response 
(Figure 1.3) (Ali et al. 2014). This possibly protective role of wild type Siglec-14 allele 
against preterm birth is in contrast with its association with exacerbation of disease 
symptoms (Figure 1.3): for instance, patients with increased Siglec-14 allele dosage are 
more likely to experience exacerbation of chronic obstructive pulmonary disease (COPD) 
symptoms, such as tightening of airways, increased mucus production, inflammation, and 
reduced amount of airflow, when infected with nontypeable Haemophilus influenzae 
(NTHi) (Angata et al. 2013): this is thought to be due to the strong pro-inflammatory 
immune reactions mounted by the Siglec-14 wildtype allele. Similarly, the Siglec-14 null 
allele is associated with increased protection against Mycobacterium tuberculosis in a 
Vietnamese patient cohort (Graustein et al. 2017). While the exact nature of the protective 
effect against this disease is yet unclear, one possible mechanism may involve IL-2: 
Siglec-14 null allele is associated with increased secretion of pro-inflammatory IL-2 in 
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response to BCG stimulation (Graustein et al. 2017). As IL-2 is associated with Th1 type 
adaptive immune responses (Zhou et al. 2003), this could partly explain the increased 
efficiency with which the causative pathogen is cleared from individuals with the Siglec-
14 null allele. In this regard, it is interesting to note that Siglec-14 null allele frequency 
varies among different populations, with the frequencies being highest among East and 
South Asians, followed by middle Eastern populations, sub-Saharan Africans, and lowest 
in Northern Europeans (Yamanaka et al. 2009).  
 
As pregnancy requires careful immune modulation both at the local and systemic level, it 
is possible that other immunity genes have experienced selective pressures arising from 
both reproductive processes and host defense activities. For instance, galectins are 
known to be involved in both modulation of immune responses during infection (Ideo et 
al. 2009; Yang et al. 2011) and suppression of detrimental immune responses at the 
maternal-fetal interface (Kopcow et al. 2008; Tirado-González et al. 2013). More broadly, 
a recent study uncovered several precisely timed events of systemic immune modulations 
that occur over the course of a normal pregnancy (Aghaeepour et al. 2017). While studies 
comprehensively examining the recent evolution of genes involved in such immune 
pathways are yet lacking, we hypothesize that the patterns of genetic variation of these 
genes would reflect selection acting on both reproductive success and efficient host 
defense. 
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In conclusion, these examples suggest that selection on reproductive success and 
effective host defense often acts in opposing directions, and that the patterns of genetic 
variation of these genes observed in present populations often reflect the action of 
selection on both factors in the context of environmental factors.  
 
Summary 
The evolution of mammalian, and more specifically, eutherian pregnancy is characterized 
by several innovations, which have been enabled by extensive re-wiring of regulatory 
networks to incorporate pre-existing genes to participate in pregnancy, and the 
emergence of novel genes that are involved in more pregnancy-specific roles. Regulatory 
evolution has been facilitated by contribution of regulatory regions by TEs that provided 
binding sites for TFs that play critical roles in pregnancy and similarly, LTRs of ERVs that 
can act as novel cis-regulatory regions. Gene duplication events followed by species-
specific expansions, as well as co-option ERV-derived genes, underlie the birth of new 
genes in eutherians. Interestingly, while there are exceptions, genes involved in immune 
regulation were recruited into expression within reproductive tissues (Lynch et al. 2015) 
and also newly emerged within eutherians (Cao et al. 2009; Kammerer and Zimmermann 
2010; Dunwell et al. 2017). This could partly be explained by the need for careful 
regulation of the maternal immune system during eutherian pregnancy, due to the 
extended direct maternal-fetal contact that happens throughout the majority of the 
gestational period. For instance, in humans, T cell activities are strongly suppressed at 
the maternal-fetal interface by induction of apoptosis via Fas-FasL signaling, starvation 
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of these cells by tryptophan depletion by indolamine (IDO) 2,3-dioxygenase, and 
expression of PD-L1 on T cells (Jerzak et al. 2011). In addition, differentiation of 
regulatory T cells with anti-inflammatory properties (Somerset et al. 2004), alternative 
activation of macrophages leading to suppression of cytotoxic T cell activities (Svensson 
et al. 2011), reduced production of costimulatory molecules and increased secretion of 
Th2 cytokines by dendritic cells occur at the maternal-fetal interface (Martínez et al. 2012) 
as well, creating an immunologically tolerant environment for the growth of the fetus.   
 
 
 
Figure 1.4. Changes in the maternal immune system that occur during pregnancy 
and the genetic elements that are involved in this process. This figure summarizes 
the changes in the maternal immune system that happen during pregnancy and the 
genetic elements that are potentially associated with such changes. a) Different 
components of the maternal immune system experience alternations in their activities 
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over the course of gestational period: more specifically, activities of monocytes, dendritic 
cells, granulocytes, and regulatory T cells (Treg cells) increase over the course of 
pregnancy, especially starting in 2nd trimester. In contrast, activities of CD4+ and CD8+ T 
cells, as well as natural killer cells, decrease with gestational age. Involved in this immune 
modulation process are b) reproductive immunity genes and potentially, c) enhancers, 
especially the ones expressed in the placenta.  
 
In humans, starting from second trimester and onwards, shed off SYN microparticles 
(likely resulting from trophoblastic apoptosis that is involved in continuous renewal of the 
SYN) can be detected in the maternal circulation (Germain et al. 2007). These floating 
microparticles come into close contact with maternal immune cells and the peripheral 
immune system is therefore modulated to down-regulate detrimental cell-mediated 
immunity (Figure 1.4a) (Sacks et al. 1999; Kanai et al. 2001; Somerset et al. 2004).  
Conversely, it has been shown that certain components of the innate immune system are 
activated to compensate for this relative suppression of cell-mediated immune activities: 
circulating innate immune cells exhibit activated phenotypes and are primed to produce 
pro-inflammatory cytokines upon stimulation (Figure 1.4a) (Sacks et al. 1999; Sacks et 
al. 2003). These alert innate immune components must be carefully regulated and loss 
of control (and subsequent excessive activation) has been linked to pregnancy 
complications (Sacks et al. 1998; Redman et al. 1999). At the same time, infectious 
diseases are a cause of considerable mortality, and therefore, pathogens represent one 
of the most important factors shaping human genetic variation among different 
populations (Fumagalli et al. 2011). As such, genes involved in host defense are often 
proposed targets of strong positive selection (Figure 1.4b). Thus, the patterns of genetic 
variation of such genes is likely a product of adaptation to local pathogen threats as well.  
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It is widely accepted that changes in gene regulation play a major role in the evolution of 
novel traits (King and Wilson 1975; Carroll 2005): this is because regulatory elements 
such as enhancers can alter expression patterns of a given gene in a particular context 
without affecting expression in others: such modular organization can therefore facilitate 
phenotypic evolution while minimizing pleiotropic effects (Carroll 2005; Wray 2007; 
Sholtis and Noonan 2010). Indeed, emergence of eutherian pregnancy is associated with 
novel regulatory elements, which are often involved in modulating the transcriptional 
activities of genes that are involved in immune responses, metabolic processes, and other 
pregnancy-specific processes (Lynch et al. 2015; Ferreira et al. 2016; Lynch et al.). In 
addition, recent studies suggest that selection on regulatory regions such as enhancers 
has contributed to recent human evolution: for instance, one study found population-level 
differences in the transcriptional responses to pathogens (Nédélec et al. 2016). In this 
regard, it is possible that the need for refined regulation of processes involved in 
pregnancy, such as immune activities, has influenced the recent evolution of these 
regulatory regions (Figure 1.4c). However, studies investigating patterns of genetic 
variation of regulatory regions involved in pregnancy are lacking. As such, future studies 
on the evolution of genetic elements involved in pregnancy could also incorporate 
regulatory regions such as promoters and enhancers.   
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Chapter previews 
In this dissertation, I studied the patterns of recent evolution of genetic elements that are 
associated with human pregnancy using various population genetics metrics that can 
detect distinct genomic signatures of selection events that happened at different time 
ranges in recent human history, as well as under different modes (i.e., hard versus soft 
selective sweeps).  
 
In Chapter II, I outline the methods I used in my studies (Chapter III and IV). In short, I 
use three metrics that are known to detect incidences of hard selective sweeps (Tajima’s 
D, FST, and nSL) and one metric that exhibits increased power towards soft selective 
sweeps (H12) into my studies. As non-adaptive processes such as past demographic 
events, as well as random processes like genetic drift can produce false signatures of 
selection, I also incorporate simulations of neutral evolution that explicitly accounts for 
these confounding factors into my studies.   
 
In Chapter III, I study the patterns of recent evolution of 55 genes that are collectively 
involved in sialic acid biology genes, to test the hypothesis that reproductive immunity 
genes have experienced recent positive selection in modern humans. I use the methods 
discussed in Chapter II: in short, I calculate the various metrics of recent positive selection 
and compare the empirical values to those calculated on the neutrally simulated 
sequences. I found that the majority of the sialic acid biology genes do not exhibit 
significant evidence of recent positive selection. However, I found that the identity of the 
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genes that do exhibit evidence of recent positive selection are different among the metrics 
calculated, suggesting that different genes have experienced selective events at different 
time ranges in recent human history. In addition, I also found that more genes exhibit 
evidence of having undergone soft selective sweeps than hard selective sweeps, 
suggesting the prevalence of soft selective sweeps in recent human evolution.  
 
In Chapter IV, I study the patterns of recent evolution of a different type of genetic 
element- enhancers. More specifically, I calculate metrics of recent positive selection on 
enhancers active in 41 human tissues and compare them to those calculated on the 
“neutrally simulated” enhancers. I first calculate the proportions of enhancers exhibiting 
significant evidence of recent positive selection. Next, I carry out functional enrichment 
analyses on the putative target genes of enhancers with significant evidence of recent 
positive selection. Third, I compare the patterns of recent evolution in enhancers among 
the different tissues, between tissue-specific and tissue-broad enhancers. I found that on 
average, 5.90% of enhancers show evidence of recent positive selection across all 
tissues and metrics studied. In addition, putative target genes of these enhancers were 
enriched for functions related to immunity. Furthermore, enhancers active in brain and 
testis were found to exhibit significant differences in the patterns of recent evolution 
compared to enhancers of other tissues: I also found that tissue-specific and tissue-broad 
enhancers show significant differences in brain and testis.  
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Together, my dissertation aims to understand how genetic elements involved in 
pregnancy have evolved in recent human history. In doing so, my research also sheds 
light on the challenge associated with interpreting the results of such studies.  
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CHAPTER II 
 
Summary of the population genetics methods  
used in this dissertation 
 
Abstract 
 
Since their origin in Africa approximately 250,000 - 200,000 years ago, modern humans 
have undergone several massive changes, which have exposed them to novel selective 
pressures. Adaptation to such changes has likely left signatures on the genomes of 
modern humans, in the form of changes in both allele and haplotype frequencies. The 
availability of high quality whole genome sequence data that spans numerous 
populations, coupled with various population genetics metrics that can capture distinct 
aspects of genetic variation present within extant humans, has enabled detecting 
episodes of past recent positive selection that occurred at different time periods in human 
history. In this chapter, I briefly discuss the population genetics metrics I have used in my 
research and how these metrics can be utilized in detecting selection events that took 
place throughout different time periods in recent human history. As these metrics are 
affected by past demographic events, I also describe how simulations of neutral evolution 
that explicitly account for past demographic events can be used to avoid false positive 
instances of recent positive selection. 
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Introduction 
 
Since the emergence of the anatomically modern humans in Africa approximately 
200,000 - 250,000 years, several distinctive events have happened (Figure 2.1): 
approximately 50,000 to 75,000 years ago, modern humans left Africa and spread out to 
novel environments worldwide; the Eurasian population split into modern Europeans and 
Asians approximately 36,000 to 45,000 years ago; the Agricultural Revolution occurred 
around 10,000 to 20,000 years ago, resulting in the emergence of farming practices and 
establishment of communal living (Sabeti et al. 2006; Karlsson et al. 2014; Page et al. 
2016). All of these major events have exposed human populations to novel selective 
pressures such as new pathogens and dietary changes. The resulting selection events 
have would have likely left genomic signatures, including changes in allele and haplotype 
frequencies. Therefore, examining patterns of genetic variation in present day humans 
could shed light on the actions of past selection events. In this regard, a number of studies 
have been carried out to uncover the consequences of past selection events on the 
human genome (Voight et al. 2006; Sabeti et al. 2007; Pickrell et al. 2009). 
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Figure 2.1. Several major events happened in recent human history in the past 
200,000 - 250,000 years. 
 
Studies of recent evolution require large-scale genetic variation data. Throughout the 
years, improvements in sequencing technology have made high quality whole genome 
sequencing data readily available, facilitating large-scale population genetics analyses 
(Pool et al. 2010; Fumagalli et al. 2013; Wall et al. 2017). For example, the efforts of the 
final phase of the 1000 Genome Project (Phase III), aided by improvement in sequence 
data accuracy, genotype calling, and phasing algorithms, has resulted in the collection of 
whole genome sequence data from over 2,500 individuals belonging to 26 different 
subpopulations, which are further classified into five super groups: Africans, Europeans, 
East Asians, South Asians, and Americans (The 1000 Genomes Project Consortium et 
al. 2015). Furthermore, new metrics that are sensitive to various genomic signatures 
(Biswas and Akey 2006; Vitti et al. 2013) have expanded the inferences of past selection 
that can be made (Figure 2.2). In addition, software that are capable of simultaneous 
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analysis of the sequence data from large number of individuals have been developed 
(Danecek et al. 2011; Pfeifer et al. 2014; Szpiech and Hernandez 2014), further facilitating 
large scale studies of recent selection (Figure 2.2). In the following sections, I will discuss 
in more detail the metrics of recent positive selection I used for my research and how 
each metric can shed light on the actions of past selection that have acted on genomic 
regions of interest in modern humans.  
	
Hard selective sweep model 
Also referred to as to classical selective sweeps, hard selective sweeps occur when a 
single advantageous variant arises after the onset of selection and sweeps (i.e., increases 
in frequency) within the population, eventually becoming fixed in the population (i.e., 
reaches a frequency of 100%) (Messer and Petrov 2013). As the selected variant rises in 
frequency within the population, linked neutral variants also become more prevalent, 
drastically reducing genetic diversity in the region surrounding the selected locus (Figure 
2.2). This results in several distinctive genomic signatures, such as excess of rare alleles, 
increased population differentiation, and the presence of a single long, dominant 
haplotype (Sabeti et al. 2006; Messer and Petrov 2013). In addition, different metrics have 
been shown to be capable of detecting genomic signatures of selection that happened 
over different time ranges throughout recent human history (Sabeti et al. 2006; Voight et 
al. 2006) (Figure 2.2). For instance, Tajima’s D, a metric that compares the average 
number of pairwise differences (p) with the number of segregating sites (q), can detect 
excess of rare alleles (Tajima 1989) that have resulted from selective sweeps. More 
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specifically, negative values of Tajima’s D, which reflect presence of more segregating 
sites than pairwise differences, are indicative of selective sweeps. This is because 
selective sweeps often result in the presence of one dominant haplotype within a 
population and therefore, any new mutation is likely to be rare. As mutagenesis is rare in 
humans, this signature persists for a relatively long period of time and therefore, Tajima’s 
D has been proposed to be able to detect selection events that happened approximately 
200,000 - 250,000 years ago, or around the origin of modern humans (Figure 2.2) (Sabeti 
et al. 2006).  
 
	
Figure 2.2. Actions of selection at different time ranges in human history leave 
distinct types of genomic signatures that can be detected by various population 
genetics metrics. This figure illustrates how calculating population genetics metrics 
using the genotype data of modern human populations can shed light on selection events 
that happened in the past. Different population genetics metrics are sensitive to distinct 
types of genomic signatures resulting from the action of recent selection. In addition, as 
these genomic signatures persist for different lengths of time, these metrics can be used 
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to infer selection events that happened in different time ranges in human history. For 
instance, Tajima’s D detects the excess of rare alleles, which persist for the longest period 
of time because mutagenesis is rare in humans. Therefore, Tajima’s D can be used to 
infer selection events that happened approximately 200,000 to 250,000 years ago. In 
contrast, the presence of extended linkage disequilibrium (or haplotype) breaks down 
relatively quickly by recombination and therefore, this signature remains for the shortest 
period of time. nSL is sensitive to such signatures and therefore, can be used to detect 
selection events that happened approximately 10,000 to 20,000 years ago. 
 
Following the out-of-Africa migration that occurred approximately 50,000 - 75,000 years 
ago, humans that settled in new environments worldwide would have been exposed to a 
suite of novel selective agents. Local adaptations to different environments are expected 
to result in differences in allele frequencies among geographically distinct populations 
(i.e., increased population differentiation), which can be detected by a metric called 
fixation index (FST) (Figure 2.2) (Wright 1951). Multiple estimators have been developed 
for this metric (Nei 1973) (Nei 1986; Weir and Cockerham 1984), and for my studies, I 
used the estimator developed by Weir and Cockerham (Weir and Cockerham 1984), 
which is unbiased in terms of sample sizes of the populations being examined.  
 
As briefly mentioned above, one characteristic signature of hard selective sweeps is the 
presence of a single, extended haplotype within the population, which results from hitch-
hiking of linked neutral variants along with the selected variant (Figure 2.2) (Biswas and 
Akey 2006; Sabeti et al. 2006; Voight et al. 2006; Messer and Petrov 2013). Metrics such 
as extended haplotype homozygosity (EHH) (Sabeti et al. 2007) that 1) measure the 
decay of linkage disequilibrium (LD) of the selected variant with others over varying 
distances, or 2) integrate EHH values over a specified distance surrounding a variant of 
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interest (e.g., integrated haplotype score or iHS) (Voight et al. 2006) can be used to detect 
such genomic signatures. As recombination can rapidly break down the haplotype, this 
signature persists for the shortest period of time, and can be used to infer selection events 
that happened approximately 10,000 to 20,000 years ago, or around the Agricultural 
Revolution (Figure 2.2). In addition, haplotype-based metrics also exhibit increased 
sensitivity to incidences of incomplete or partial selective sweeps, in which the selected 
variant does not reach complete fixation (i.e., reaches an intermediate frequency of 65 - 
85%) (Sabeti et al. 2006; Voight et al. 2006). I used nSL (Number of Segregating Sites by 
Length; (Ferrer-Admetlla et al. 2014)), a metric that is very similar to iHS but more robust 
to variations in recombination rates (Figure 2.2) (Ferrer-Admetlla et al. 2014). More 
specifically, nSL integrates EHH values calculated over various intervals from the 
specified variant by using number of segregating sites as proxy for distance, while iHS 
instead uses recombination distance for integration. Similar to iHS, higher absolute values 
of nSL indicate the presence of long haplotypes, and therefore, the action of selective 
sweeps on the variant of interest.   
 
Alternative mode of selection: soft selective sweep model 
While hard selective sweeps have been the most widely studied mode of recent selection 
in humans, it has been recently argued that this may not be the dominant mode of 
selection in modern humans (Pennings and Hermisson 2006a; 2006b; Hernandez et al. 
2011; Messer and Petrov 2013). Recently proposed as an alternative mode of selection, 
soft selective sweeps occur when standing variation or multiple de novo mutations 
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introduce several variants into the population (Pennings and Hermisson 2006a; Messer 
and Petrov 2013). In either scenario, soft selective sweeps result in the presence of more 
than one, independent haplotypes within a population (Figure 2.3). As no single variant 
becomes completely fixed, there is no drastic reduction in genetic diversity as seen in the 
case of hard selective sweeps. Therefore, metrics designed to detect hard selective 
sweeps are known to have very low power to detect signatures resulting from such soft 
selective sweeps (Messer and Petrov 2013). For instance, one study found that while 
Tajima’ D retains power to detect incidences of selective sweeps resulting in allele 
frequencies close to 100% (reflective of hard selective sweeps), it quickly loses power as 
the allele frequency falls to more moderate levels (65-85%) (Ferrer-Admetlla et al. 2014). 
In this regard, Garud et al. devised a novel metric, the H12, that combines the frequencies 
of the most common haplotype (H1) and the second most common haplotype (H2) (Figure 
2.3) (Garud et al. 2015). While still biased towards detecting hard selective sweeps, 
Garud et al. showed that H12 exhibits increased power to detect soft selective sweeps 
compared to other metrics such as iHS, as long as the sweeps are not “too soft” (i.e., 
selection has acted on multiple variants, resulting in a high number of independent 
haplotypes being present within a population) (Garud et al. 2015).  
 
	 53	
 
Figure 2.3. Different population genetics metrics have power to distinguish 
signatures left by distinct modes of selection. This figure compares two models of 
selective sweeps: hard and soft selective sweeps. Under a hard selective sweep model, 
a single advantageous variant rises in frequency within the population after the onset of 
selection, resulting in drastic reduction in genetic diversity in the region surrounding the 
selected variant. In contrast, soft selective sweeps occur when selection acts on multiple 
variants (arising from either standing variation or multiple de novo mutations), resulting in 
the presence of multiple, independent haplotypes within the population. Metrics such as 
Tajima’s D, Weir & Cockerham’s FST, and nSL are known to detect incidences of hard 
selective sweeps, whereas H12, which is a metric of pooled haplotype homozygosity, has 
increased power to detect soft selective sweeps.  
 
Simulations of neutral evolution 
Actions of past demographic events, such as population expansion and/or contraction 
can result in similar changes in genetic variation as selection (Sabeti et al. 2006; Nielsen 
et al. 2007). For instance, during a bottleneck event, rare alleles are likely to get removed 
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from a population due to sampling effect, resulting in positive values of Tajima’s D (i.e., 
excess of alleles with intermediate frequencies) (Figure 2.4). Immediately after such a 
bottleneck event, Tajima’s D values will drop to negative values, as genetic diversity has 
been dramatically reduced and new mutations emerging afterwards will initially be rare 
(Figure 2.4). As the population expands, more rare mutations will arise via de novo 
mutations, and as a result, Tajima’s D values will further decrease (Figure 2.4). This 
example demonstrates how non-adaptive processes alone can change the values of 
metrics of recent positive selection. Therefore, if past demographic events are not 
accounted for, one could incorrectly conclude that a region has undergone selection 
(Nielsen et al. 2007) in the absence of selection. 
 
	
Figure 2.4. Confounding effects of past demographic events in studies of recent 
positive selection. This example illustrates how non-adaptive processes such as 
changes in population size can alone alter the values of the metrics of recent positive 
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selection in the absence of selection. An extreme contraction in population size (i.e., 
bottleneck) would likely result in deficiency of rare alleles due to sampling effect, resulting 
in positive values of Tajima’s D. As the population recovers from such a bottleneck event, 
novel rare mutations will emerge via de novo, lowering the values of Tajima’s D.  
	
One way to account for the confounding effects of non-adaptive processes is to generate 
sequences that evolved neutrally while experiencing similar demographic events as 
modern humans (Figure 2.5). Metrics of recent positive selection then can be calculated 
on such neutrally simulated sequences and compared to the observed values. Several 
attempts, including that of Gravel and his colleagues (Plagnol and Wall 2006; Nielsen et 
al. 2009; Gravel et al. 2011), have been made to infer parameters of past demographic 
events. For instance, Gravel et al. estimated maximum likelihood parameters for three 
super-populations (Africans, Europeans, East Asians) by combining low-coverage whole 
genome data and high-coverage targeted exon data of the pilot phase 1000 Genomes 
Project (Gravel et al. 2011). Inferred parameters include effective population sizes, 
migration rates, mutation rates, magnitudes of changes in the population, and timing of 
major splitting events.  
 
	
	 56	
	
Figure 2.5. Simulations of neutral evolution. A schematic illustration of simulations of 
neutral evolution. Pre-estimated parameters of past demographic events including 
migration rates and magnitude of population size changes, as well as other attributes 
associated with the “actual” region of interest such as recombination rates and length of 
the region can be incorporated into simulations of neutral evolution to create “simulated” 
regions that closely match the “actual” region. In my studies, I carried out 2,500 (for 
generating regions used for nSL calculations) to 10,000 (for other metrics) simulations of 
neutral evolution. 
 
Simulation programs such as SLiM allow execution of complicated simulations of neutral 
evolution with explicit incorporation of the estimated demographic parameters (Messer 
2013; Haller and Messer 2017). To create a neutrally “simulated” region that matches the 
“actual” region of interest as closely as possible, other attributes (derived from the 
empirical data) such as recombination rate and length of the genetic region can be 
specified as well (Figure 2.5). To assess the likelihood that the observed metrics of recent 
positive selection have resulted from actions of selection, these values can be compared 
to the distribution of same metrics calculated on the neutrally simulated sequences 
(Figure 2.6). An empirical p-value, calculated as the proportion of simulated sequences 
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that exhibit values equal to or more extreme than the observed value, can be calculated 
and compared to a pre-set significance threshold. For my studies, I used a p-value cutoff 
of 0.05. In short, a p-value lower than 0.05 indicates significant deviations from 
expectations of neutral evolution and therefore, significant evidence of recent positive 
selection (Figure 2.6).   
	
	
Figure 2.6. Assessing significance of the empirical metrics of recent positive 
selection. A schematic illustration of assessing whether a region of interest exhibits 
significant deviations from neutral expectations (i.e., exhibits evidence of recent positive 
selection). The empirical value of the calculated metric can be compared to the 
distribution of values calculated using the neutrally simulated sequences. Empirical 
values that are “more extreme” than the 95% percentile of distribution of neutrally 
simulated values are considered significant.   
 
Software and commands 
More detailed and specific commands for the software used in each of my studies, as well 
as the location of the data files used, can be found in Additional Files 3.1 and 4.1. In this 
section, I will briefly outline the software and the generalized commands that were used 
to calculate each metric of recent positive selection.  
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For calculations of Weir & Cockerham’s FST, I used VCFtools (v.0.1.13) (Danecek et al. 
2011). I calculated the global FST among three super populations (Africans, Europeans, 
East Asians) using the following command:  
 
./vcftools --gzvcf input.vcf.gz --chr chr_id --from-bp start_pos --to-bp end_pos --remove-
indels --weir-fst-pop AFR_ --weir-fst-pop EUR --weir-fst-pop EAS --out output  (1) 
 
‘input.vcf.gz’ refers to the compressed VCF file, sorted by chromosome, containing the 
genotype data, created by the 1000 Genomes Project. ‘chr_id’ indicates the chromosome 
on which the region of interest in located on. ‘start_pos’ and ‘end_pos’ refer to start and 
end positions of the region of interest, in base pairs, respectively. ‘AFR’, ‘EUR’, and ‘EAS’ 
refer to files that list the individuals labeled as Africans, Europeans, and East Asians in 
the 1000 Genomes Project data, respectively.  
 
Tajima’s D was calculated using the R package PopGenome (version 2.1.6) (Pfeifer et al. 
2014), via the “neutrality.stats” function as follows: 
 
Input_vcf <- readVCF(input_vcf, 1000, tid = chromosome_id, from = start_pos, to = 
end_pos, approx. = FALSE) (2) 
all_pops <- as.character(read.table(3pops_samples_list))[[1]] (3)  
Input_neut_all_pops <- neutrality.stats(input_vcf_data, list(all_pops)) (4)  
Input_TajimaD_all_pops <- input_neut_all_pops@Tajima.D[[1]] (5)  
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The first line reads the input VCF file containing the genotypes in the region of interest 
(‘input_vcf’), from ‘start_pos’ to ‘end_pos’. The second line reads the file listing the IDs of 
all individuals belonging to the 3 populations (Africans, Europeans, East Asians) 
(‘3pops_samples_list’) into R. The third line computes a set of neutrality statistics, 
including Tajima’s D Fu and Li’s D* and F*, using the genotype file read from (2) of 
individuals belonging to the 3 populations of interest that have been called using (3).  The 
last line extracts the value of Tajima’s D from the list of neutrality statistics calculated in 
the previous step.  
 
Next, for the calculation of nSL, I used Selscan (version 1.2.0) (Szpiech and Hernandez 
2014) using the following command: 
 
./selscan --nsl --vcf input_vcf --maf 0.01 --threads 16 --out output (6) 
 
As with other metrics, ‘input_vcf’ refers to the VCF file that contains genotype data 
spanning the region of interest. Apart from the minor allele frequency cutoff value (0.01), 
I used the default settings of Selscan. The maximum absolute value of the unstandardized 
nSL calculated over the entire window was used to represent the entire region of interest 
being examined.  
 
Finally, I used SLIM (Messer 2013; Haller and Messer 2017) to generate VCF files of 
variants resulting from the action of neutral evolution alone, given past demographic 
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events. I incorporated SLiM’s implementation of Gravel et al’s pre-computed parameters 
of human demographic history (Gravel et al. 2011) into my neutral simulations. More 
specifically, at the beginning of the simulation (i.e. generation 1), the ancestral African 
effective population size was set to 7,310, which next expanded to 14,474 approximately 
148,000 years ago (i.e. 5,920 generations ago). Approximately 51,000 years ago (i.e. 
2,040 generations ago), the non-Africans split from Africans; the initial effective population 
size of these non-Africans was set to 1,861. The migration rates between Africans and 
non-Africans were set to 15 x 10-5. Next, approximately 23,000 years ago (i.e. 920 
generations ago), the above-mentioned non-African population split into European and 
East Asian populations, with the initial effective population size for East Asians set to 554. 
In the same generation, the European effective population size was reduced to 1,032.  
The following migration rates were established for the remainder of the simulation: 2.5 x 
10-5 for between Africans and Europeans, 0.78 x 10-5 for between Africans and Asians, 
and 3.11 x 10-5 for between Europeans and East Asians.  Between generations 57,080 
and 58,000, the European and East Asian populations were set to experience increase 
in their effective population sizes: for Europeans, the exponential coefficient was 0.0038 
and 0.0048 for East Asians. For each region being studied, I set the length of the genomic 
element being simulated equal to the length of the region of interest. For instance, to 
simulate a region that is 1,000bp long, the following argument was used: 
 
initializeGenomicElement(g1, 0, 999) (7) 
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After 58,000 generations (i.e. end of the simulation), I sampled 661, 503, and 504 
individuals from the “simulated” African, European, and East Asian population, 
respectively, to match the number of individuals included in the 1000 Genomes Project 
dataset. I used the following arguments to ensure that pairs of genomes being sampled 
belonged to the same individual:  
 
p1_sample = p1.individuals; (8) 
sampled_p1 = sample(p1_sample, 661); (9) 
p2_sample = p2.individuals; (10) 
sampled_p2 = sample(p2_sample, 503); (11) 
pe_sample = p3.individuals; (12) 
sampled_p3 = sample(p3_sample, 504); (13) 
 
p1, p2, and p3, correspond to the simulated African, European, and East Asian 
populations. Finally, to specify the output format as VCF, I used the commands shown 
below: 
  
sampled_individuals = c(sampled_p1, sampled_p2, sampled_p3); (14) 
sampled_individuals.genomes.outputVCF(); (15) 
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CHAPTER III 
 
Examination of signatures of recent positive selection on genes involved in human  
sialic acid biology2,3 
 
Abstract 
Sialic acids are nine carbon sugars ubiquitously found on the surfaces of vertebrate cells 
and are involved in various immune response-related processes. In humans, at least 58 
genes spanning diverse functions, from biosynthesis and activation to recycling and 
degradation, are involved in sialic acid biology. Because of their role in immunity, sialic 
acid biology genes have been hypothesized to exhibit elevated rates of evolutionary 
change. Consistent with this hypothesis, several genes involved in sialic acid biology have 
experienced higher rates of non-synonymous substitutions in the human lineage than 
their counterparts in other great apes, perhaps in response to ancient pathogens that 
infected hominins millions of years ago (paleopathogens). To test whether sialic acid 
biology genes have also experienced more recent positive selection during the evolution 
of the modern human lineage, reflecting adaptation to contemporary cosmopolitan or 
geographically-restricted pathogens, we examined whether their protein-coding regions 
showed evidence of recent hard and soft selective sweeps. This examination involved the 
calculation of four measures that quantify changes in allele frequency spectra, extent of 
population differentiation, and haplotype homozygosity caused by recent hard and soft 
																																																						
2 This chapter was published in G3. 2018 April 1;8:4. doi.org/10.1534/g3.118.200035 
3 The contributing authors are: Jiyun M. Moon, David M. Aronoff, John A. Capra, Patrick 
Abbot, and Antonis Rokas.  
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selective sweeps for 55 sialic acid biology genes using publicly available whole genome 
sequencing data from 1,668 humans from three ethnic groups. To disentangle evidence 
for selection from confounding demographic effects, we compared the observed patterns 
in sialic acid biology genes to simulated sequences of the same length under a model of 
neutral evolution that takes into account human demographic history. We found that the 
patterns of genetic variation of most sialic acid biology genes did not significantly deviate 
from neutral expectations and were not significantly different among genes belonging to 
different functional categories. Those few sialic acid biology genes that significantly 
deviated from neutrality either experienced soft sweeps or population-specific hard 
sweeps. Interestingly, while most hard sweeps occurred on genes involved in sialic acid 
recognition, most soft sweeps involved genes associated with recycling, degradation and 
activation, transport, and transfer functions. We propose that the lack of signatures of 
recent positive selection for the majority of the sialic acid biology genes is consistent with 
the view that these genes regulate immune responses against ancient rather than 
contemporary cosmopolitan or geographically restricted pathogens.  
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Introduction 
Sialic acids are nine carbon sugars that are commonly found on the ends of 
glycoconjugates in deuterostome animals (Schauer 1982; Varki 2007). These molecules 
are involved in several biological processes, such as intercellular adhesion and signaling 
(Kelm and Schauer 1997; Varki and Varki 2007), and play important roles in the 
modulation of various aspects of the host immune system (Pilatte et al. 1993; Varki and 
Gagneux 2012) including activation of immune responses, leukocyte trafficking, 
complement pathway activation, and microbial attachment. Modification of sialic acid 
molecules during their biosynthesis and subsequent attachments to underlying sugars via 
different linkages give rise to a diverse repertoire of sialic acids (Angata and Varki 2002; 
Varki and Varki 2007; Cohen and Varki 2010; Hayakawa and Varki 2011). 
 
More than 50 genes are known to be involved in various aspects of sialic acid biology in 
humans, and they fall into five broad functional categories (Altheide et al. 2006): 1) 
biosynthesis, 2) activation, transport, and transfer, 3) modification, 4) recognition, and 5) 
recycling and degradation (Figure 3.1). Biosynthesis genes are involved in assembling 
sialic acids from precursor molecules in the cytosol, while genes involved in the second 
category activate the sialic acids by attaching cytidine monophosphate to them, transport 
the activated sialic acids to the Golgi for attachment to glycoconjugates via multiple forms 
of α linkages, and transfer them to the cell surface. Activated sialic acids that are linked 
to the underlying sugar can be further modified by incorporation of additional molecules 
before the sialylated glycoconjugate is transferred to the cell surface. At the cell surface, 
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sialic acids are recognized by specialized receptors and finally, the used sialic acids end 
up in the lysosome for recycling and degradation (Altheide et al. 2006). 
	
	
Figure 3.1. Summary of the biochemical processes involved in human sialic acid 
biology and the genes known to be associated with them 
 
Both the large number of genes involved in human sialic acid biology and their high 
sequence diversity have been hypothesized to be a result of ancient selective pressures 
from paleopathogens that infected hominins millions of years ago and left their signatures 
on genes involved in sialic acid biology (Varki 2009). The most striking example involves 
the Alu-mediated inactivation of the CMAH gene specifically in the human lineage (Chou 
et al. 1998; Irie et al. 1998; Varki 2001): the enzyme encoded by this gene is responsible 
for the conversion of N-acetylneuraminic acid (Neu5Ac) to N-glycolylneuraminic acid 
(Neu5Gc), and Neu5Ac is the main form of sialic acid in humans. This change in sialic 
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acid composition has been suggested to act as a means to escape infection by 
Plasmodium reichenowi, a parasite that preferentially binds to Neu5Gc and is known to 
cause malaria in chimpanzees. Conversely, adoption of Neu5Ac likely made humans 
susceptible to infection by the malaria parasite Plasmodium falciparum, which instead 
binds to Neu5Ac (Martin et al. 2005; Varki and Gagneux 2009). Additionally, in contrast 
to humans, the inhibitory receptor Siglec-5 and its immune-stimulatory counterpart Siglec-
14 in great apes lack the essential arginine residue required for optimal binding with sialic 
acids, likely as a consequence of the above-mentioned switch from Neu5Gc to Neu5Ac 
in the human lineage (Angata et al. 2006). Finally, molecular evolutionary analyses in 
primates and rodents have shown that genes involved in sialic acid recognition exhibit a 
considerable degree of sequence divergence, even between closely related species, 
suggestive of ancient positive selection in response to paleopathogens (Altheide et al. 
2006).  
 
The examples above suggest that sialic acid biology genes experienced adaptive 
changes early in the evolutionary radiation of primates, including hominids and hominins. 
However, whether these same genes also experienced positive selection during recent 
human evolution (i.e., in the last 250,000 years), reflective of adaptation to contemporary 
pathogens, remains an open question. To test this hypothesis, we estimated the 
population-level genetic variation of the protein-coding regions of sialic acid biology 
genes, and carried out tests aimed to detect hard selective sweeps, including tests of 
deviation from neutrality (measured by Tajima’s D; Tajima 1989), population 
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differentiation (measured by FST; Weir and Cockerham 1984), and extended haplotype 
homozygosity (measured by nSL; Ferrer-Admetlla et al. 2014) using the 1000 Genomes 
Project sequencing data from 1,668 humans belonging to three ethnic groups (Auton et 
al. 2015). To also test for the possible action of soft selective sweeps, we employed H12 
(Garud et al. 2015), a measure of modified pooled haplotype homozygosity. To determine 
whether sialic acid biology genes exhibit patterns of genetic variation that deviate from 
neutral expectations, we compared the values of each of these four measures for sialic 
acid biology genes against those from sequences of the same length simulated under 
neutral evolution assuming a realistic model of human demographic history (Gravel et al. 
2011; Messer 2013; Haller and Messer 2017). Examination of patterns of genetic variation 
of sialic acid biology genes showed that, irrespective of their functional category, most of 
them conform to neutral expectations. Sialic acid biology genes that deviate from 
neutrality exhibit evidence of either temporally or spatially varying positive selection. For 
example, both recognition genes SIGLEC5 and SIGLEC12 show nSL values in 
Europeans that are consistent with the occurrence of a selective sweep approximately 
20,000 years ago, whereas the Tajima’s D value of the recycling and degradation gene 
SIAE suggests that it experienced a hard selective sweep long before the out-of-Africa 
migration, approximately 250,000 years ago. Combined with previous work showing the 
widespread occurrence of ancient positive selection on genes involved in sialic acid 
biology prior to the emergence of modern humans (Altheide et al. 2006), our results 
suggest that the evolution of human sialic acid biology genes has been more strongly 
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influenced by ancient primate pathogens rather than by contemporary cosmopolitan or 
geographically-restricted human pathogens. 
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Methods 
Genotype dataset  
To examine whether sialic acid biology genes have experienced positive selection during 
recent human evolution, for all analyses we used the genotype data for 1,668 individuals 
from three ethnic backgrounds (661 Africans, 503 Europeans, and 504 East Asians) from  
Phase 3 of the 1000 Genomes Project  (for information on data sources, see Additional 
File 3.1) (Auton et al. 2015).  
 
Sialic acid biology genes  
To identify all the genes involved in human sialic acid biology, we started from a previously 
published list of 55 loci (Altheide et al. 2006) and added SIGLEC14 and SIGLEC16, which 
were discovered more recently, as well as SIGLEC15, which was not included in the 
previous study. As sex-linked genes tend to exhibit different patterns of genetic variation 
than genes located on autosomal chromosomes (Schaffner 2004), we excluded the two 
genes that are located on the X chromosome, L1CAM and RENBP; in addition, we 
removed CMAH, the sole gene involved in modification of newly synthesized sialic acids 
because it is a non-functional pseudogene in humans (Chou et al. 1998; Irie et al. 1998). 
Thus, 55 genes were retained for subsequent analyses (Figure 3.1).  
 
To extract genotypes for these 55 genes, we used VCFtools, version 0.1.13 (Danecek et 
al. 2011) (for specific commands used, see Additional File 3.1), with the gene coordinates 
(GRCh37p.13) obtained from Ensembl (release 75) via BioMart as input; indels were 
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excluded from our analyses. Compressed VCF files and index files required for 
subsequent analyses were created using tabix, version 0.2.6 (Li 2011). 
 
 Measuring signatures of recent positive selection in human sialic acid biology 
genes 
To determine the levels of genetic polymorphism of sialic acid biology genes, we first 
calculated pairwise nucleotide diversity (π) (Nei and Li 1979) using PopGenome, version 
2.1.6 (Pfeifer et al. 2014). As there may have been variation in when and where human 
sialic acid biology genes experienced positive selection, we next used four different 
measures aimed to capture genomic signatures left from the action of selection at 
different time ranges during recent human evolution (Figure 3.2) (Sabeti et al. 2006).  
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Figure 3.2. Summary of the population genetics measures used in this study. This 
figure depicts the nature of the genomic signatures left by varying modes of selective 
sweeps occurring at different evolutionary time points, the measures that we use to detect 
such signatures, and the expected values for regions that have experienced selective 
sweeps (depicted in pink) compared to regions that have not (depicted in gray). (A) In a 
hard selective sweep model, a single, advantageous new variant rises to high frequency 
(‘sweeps’) within the population, dramatically reducing variation in the nearby (linked) 
neutral variants. This results in a signature of reduced levels of genetic diversity in the 
genomic region surrounding the selected variant. The Tajima’s D neutrality index 
assesses the extent of the abundance of rare variants resulting from such selective sweep 
events. As mutagenesis is rare, this signature persists for a relatively long period of time, 
and has been proposed to detect selective events that happened around the origin of 
modern humans approximately 250,000 years ago. (B) Approximately around 75,000 – 
50,000 years ago, modern humans migrated out of Africa to inhabit different parts of the 
world, resulting in exposure to new selective pressures (e.g., pathogens). Subsequent 
local adaptation events would have resulted in differences in allele frequencies among 
distinct populations (i.e., population differentiation), which can be quantified by Weir & 
Cockerham’s FST index. (C) Another genomic signature of hard selective sweeps is the 
presence of one dominant extended haplotype within the population, which stems from 
the hitch-hiking of linked neutral variants alongside the beneficial variant. As 
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recombination events eventually break down the haplotype structure, this signature 
persists for a relatively short period of time (i.e. 20,000 years). This signature can be 
quantified by measures of extended haplotype homozygosity such as nSL.  (D) In contrast 
to the hard selective sweeps, soft selective sweeps occur when standing variation or 
multiple de novo mutations introduce several beneficial alleles into the population, 
resulting in an increase in the frequency of more than one, independent haplotypes. 
Measures of pooled haplotype homozygosity that combine the frequencies of the most 
common and second-most-common haplotypes (i.e., H12) have been shown to possess 
increased power to capture the signatures resulting from such soft selective sweeps. 
	
To detect signatures left by hard selective sweeps that occurred approximately 250,000 
years ago, we calculated Tajima’s D (Figure 3.2a) (Tajima 1989) using the R package 
PopGenome, version 2.1.6 for each of the 55 genic regions (i.e., regions defined by the 
gene coordinates obtained via Ensembl) of the sialic acid biology genes (Pfeifer et al. 
2014). To detect local selection that occurred after the out-of-Africa migration 
approximately 75,000 years ago, we calculated both weighted and mean Weir & 
Cockerham’s fixation index (FST) (Figure 3.2b) (Weir and Cockerham 1984) between all 
three ethnic groups for the genic regions of sialic acid biology genes using VCFtools 
(Danecek et al. 2011). To capture signatures of selective sweeps that occurred 
approximately 20,000 years ago (Sabeti et al. 2006; Voight et al. 2007), we calculated the 
nSL statistic (number of segregating sites by length; Ferrer-Admetlla et al. 2014) (Figure 
3.2c) (Sabeti et al. 2006) using Selscan, version 1.2.0 (Szpiech and Hernandez 2014). 
For each gene, we calculated nSL for the region extending 100kb upstream and 
downstream using the default settings of Selscan; the only deviation from the default 
settings was that we used 0.01, instead of 0.05, for the minor allele frequency (MAF) cut-
off value. As extended haplotype methods are thought to detect selection events that 
happened after the out-of-Africa migration, we calculated this measure for each of the 
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three ethnic groups, rather than globally. We used the maximum absolute nSL values 
calculated over the entire window to represent each sialic acid biology gene and report 
un-standardized nSL values in this paper.  
 
Tajima’s D, Weir & Cockerham’s FST, and the nSL statistic are designed to capture 
signatures of completed or ongoing hard selective sweeps; therefore, they have limited 
power to detect incidences of soft selective sweeps, in which standing variation or multiple 
de novo mutations introduce several beneficial alleles into a population (Pennings  and 
Hermisson 2006a; Messer and Petrov 2013). To detect soft sweeps, we used the H12 
index (Figure 3.2d) (Garud et al. 2015), a modified haplotype homozygosity index that 
combines the frequency of the most common and second most common haplotypes in a 
given sample (Pennings and Hermisson 2006b). We modified the original python script 
written by Garud to carry out the calculations of H12 (Garud et al. 2015) on the genic 
regions of sialome genes. 
 
Simulations of neutral evolution 
The distribution of each of the four measures in the absence of selection can be 
influenced by demographic events and random processes, such as genetic drift. 
Therefore, to assess the probability that observed values in sialic acid biology genes 
reflect the action of selection, we compared them to those “expected” from a realistic 
neutral model that accounts for human demography. To identify any sialic acid biology 
genes that significantly deviate from selective neutrality in any of the four measures, we 
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conducted simulations of neutral evolution using SLiM, version 2.4.1 (Messer 2013; Haller 
and Messer 2017). To account for the confounding effects of past demographic events, 
we incorporated previously calculated demographic parameters for the three ethnic 
groups in our study (Gravel et al. 2011), which were estimated by combining low-
coverage whole genome data and high-coverage targeted exon data of the pilot phase 
1000 Genomes Project. More specifically, the simulation model assumes that: a) 
approximately 148,000 years ago, the ancestral African population experienced a 
population expansion from an initial effective population size of 7,310 to 14,474, b) the 
out-of-Africa migration occurred approximately 51,000 years ago, c) the subsequent 
Eurasian split happened approximately 23,000 years ago, d) after the Eurasian split, a 
bottleneck event in the European population reduced its effective size to 1,032 
individuals, e) for the last 23,000 years, both the European and the East Asian populations 
each experienced an exponential growth in effective population size (exponential 
quotients for Europeans: 0.0038; exponential quotients for East Asians: 0.0048), and f) 
both the recombination rate (1.0 x10-8 recombination events per bp) and the mutation rate 
(2.36 x 10-8 mutations per bp) were fixed. More detailed information on the parameters 
used for the simulations can be found in the Additional File 3.1.  
 
Using this model and parameters, we simulated the genotypes of 661, 503, and 504 
individuals corresponding to the number of individuals that we have genotype data from 
the African, European, and East Asian groups, respectively. For each gene, we carried 
out 5,000 simulations to create neutrally-evolved sequences of the same length. We next 
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used these simulated sequences to calculate Tajima’s D, Weir & Cockerham’s FST, and 
H12 values as described above. To calculate nSL values, we used SLiM to simulate 2,500 
genomic regions that extend 100kb upstream and downstream a “simulated sialic acid 
biology gene”. nSL values were calculated on these regions using Selscan as described 
above. For all tests, we calculated the p-value for a given gene as the proportion of values 
on simulated sequences that were equal to or more extreme than the observed value. 
We used a p-value of 0.05 as cutoff for significance: a gene associated with a p-value 
lower than 0.05 likely indicates 1) deviation from neutrality, and 2) patterns of variation 
are due to the action of positive selection and not due to demographic events.  
 
Statistical Analysis 
To compare the patterns of genetic variation across different functional categories of sialic 
acid biology genes, we conducted pairwise Mann-Whitney U (MWU) tests (two-sided): 
the exact p-values were calculated for each comparison via the coin package, version 
1.1-3, in the R programming environment (Hothorn et al. 2008). P-values calculated for 
comparisons among functional categories were adjusted post hoc to correct for the testing 
of multiple hypotheses via the Bonferroni method using R.  
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Results  
Most sialic acid biology genes do not exhibit signatures of recent positive selection  
To test the hypothesis that human sialic acid biology genes experienced recent positive 
selection resulting from hard selective sweeps approximately 250,000 years ago (i.e., 
around the origin of modern humans), we calculated Tajima’s D for each of the 55 sialic 
acid biology genes across our sample of 1,668 individuals (Figure 3.2a & Additional Table 
3.1). Comparison of each gene’s Tajima’s D value against the distribution of Tajima’s D 
values estimated from 5,000 simulated sequences under neutrality showed that only 2 / 
55 sialic acid biology genes exhibited significantly extreme values (SIAE, involved in 
recycling, degradation functions: p-value = 0.024; and ST3GAL2, involved in activation, 
transport, and transfer: p-value = 0.003; Figure 3.3 & Additional Table 3.1).  
	
Figure 3.3. The distribution of Tajima’s D values across the four functional 
categories of sialic acid biology genes. The graph presents the values of Tajima’s D 
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calculated for all 1,668 individuals of the 1000 Genomes Project. The 55 sialic acid biology 
genes are displayed according to the functional categories they belong to. Genes 
exhibiting significant deviation from neutral expectations (i.e., genes with p-values less 
than 0.05) are highlighted in black and their names are shown next to the data points; the 
names of all other (non-significant) genes have been omitted. The values of Tajima’s D 
for each of the 55 genes can be found in Additional Table 3.1. The number of genes 
belonging to each category is shown below the name of each functional category. 
 
To test the hypothesis that human sialic acid biology genes experienced recent local 
positive selection after the major human migration out of Africa approximately 75,000 
years ago, we calculated Weir & Cockerham’s FST between our three human populations 
for each of the sialic acid biology genes (Figure 3.2b & Additional Table 3.1). We found 
that 53 / 55 sialic acid biology genes did not exhibit significantly higher levels of population 
differentiation compared to the values calculated for 5,000 neutrally simulated sequences 
(Figure 3.4 & Additional Table 3.1); the two exceptions were the biosynthesis-involved 
NANP (p-value = 0.045) and the recognition-involved SELP (p-value = 0.035).  
	
Figure 3.4. The distribution of Weir & Cockerham’s FST values across the four 
functional categories of sialic acid biology genes. The graph presents the values of 
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weighted Weir & Cockerham’s FST values calculated by pairwise comparisons of the three 
ethnic groups. The 55 sialic acid biology genes are displayed according to the functional 
categories they belong to. Genes exhibiting significant deviation from neutral expectations 
(i.e., genes with p-values less than 0.05) are highlighted in black, their names shown next 
to the data points; the names of all other (non-significant) genes have been omitted. The 
values of the FST for each gene, along with the values of the mean Weir & Cockerham’s 
FST, can be found in Additional Table 3.1. The number of genes belonging to each 
category is shown below the name of each functional category. 
 
 
To test the hypothesis that human sialic acid biology genes experienced selective sweeps 
in one or more human populations approximately 20,000 years ago (i.e., around or shortly 
prior to the Agricultural Revolution), we calculated nSL values for the regions flanking 
100kb upstream and downstream of sialic acid biology genes within each ethic group 
(Figure 3.2c & Additional Table 3.2). For all three ethnic groups, we found that most sialic 
acid biology genes did not deviate from neutral expectations: only five genes (four 
involved in recognition and one in recycling, degradation) in Europeans (SIGLEC5: p-
value = 0.0004; SIGLEC6: p-value = 0.0004; SIGLEC12: p-value = 0.0004; SIGLEC14: 
p-value = 0.0004; and NEU2: p-value = 0.036; Figure 3.5b & Additional Table 3.2), five 
genes (three involved in recognition and two in activation, transport, and transfer) in 
Africans (LAMA2: p-value = 0.018;  ST6GALNAC1: p-value = 0.002; ST6GALNAC2: p-
value = 0.001; SIGLEC8: p-value = 0.002; and SIGLEC10: p-value = 0.002; Figure 3.5a 
& Additional Table 3.2), and four genes (two involved in recognition and two in activation, 
transport, and transfer) in East Asians (CD22: p-value = 0.046; MAG: p-value = 0.046; 
ST6GAL1: p-value = 0.001; and ST6GALNAC5: p-value = 0.030; Figure 3.5c & Additional 
Table 3.2) exhibited significant p-values. Notably, the genes exhibiting significant 
deviations from neutral expectations were different for each ethnic group.  
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Figure 3.5. The distribution of nSL values across the four functional categories of 
sialic acid biology genes. The graph presents the values of nSL values calculated for 
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each ethnic group (Africans: (A), Europeans: (B), East Asians: (C)). Unstandardized nSL 
values were calculated in windows that expand 100kb up and downstream of a given 
sialic acid biology gene: the maximum value of all the absolute nSL values in a given 
window was used to represent each gene. The 55 sialic acid biology genes are displayed 
according to the functional categories they belong to. Genes exhibiting significant 
deviation from neutral expectations (i.e., genes with p-values less than 0.05) are 
highlighted in black, their names shown next to the data points; the names of all other 
(non-significant) genes have been omitted. The values of the nSL for each gene can be 
found in Additional Table 3.2. The number of genes belonging to each category is shown 
below the name of each functional category. 
 
 
Finally, to test the hypothesis that the sialic acid biology genes experienced soft selective 
sweeps, we calculated the modified pooled haplotype homozygosity index H12 for each 
of the 55 sialic acid biology genes (Figure 3.2d & Additional Table 3.1). 10 / 55 sialic acid 
biology genes showed H12 values that significantly deviated from neutral expectations 
(NANS: p-value = 0.0004; NEU1: p-value = 0.027; NEU3: p-value = 0.001; NPL: p-value 
= 0.0004; SIAE: p-value = 0.001; SIGLEC6: p-value = 0.023; SLC35A1: p-value = 0.001; 
ST3GAL5: p-value = 0.002; ST6GALNAC1: p-value = 0.032; ST8SIA4: p-value = 0.015; 
Figure 3.6 & Additional Table 3.1). Of these 10 genes, four function in sialic acid 
activation, transport, and transfer (SLC35A1, ST3GAL5, ST6GALNAC1, and ST8SIA4), 
four in recycling and degradation (NEU1, NEU3, NPL, and SIAE), one in recognition 
(SIGLEC6) and one in biosynthesis (NANS). 
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Figure 3.6. The distribution of H12 values across the four functional categories of 
sialic acid biology genes. The graph presents the values of H12 values calculated 
across all three ethnics groups. The 55 sialic acid biology genes are displayed according 
to the functional categories they belong to. Significant pairwise functional comparisons 
are indicated with asterisks (*: p-value < 0.05; **: p-value < 0.01). Genes exhibiting 
significant deviation from neutral expectations (i.e., genes with p-values less than 0.05) 
are highlighted in black, their names shown next to the data points; the names of all other 
(non-significant) genes have been omitted. The values of the H12 for each gene can be 
found in Additional Table 3.1. The number of genes belonging to each category is shown 
below the name of each functional category. 
 
 
The four functional categories of sialic acid biology genes do not significantly 
differ in their signatures of recent positive selection 
We next examined whether the four distinct functional categories of sialic acid biology 
genes (Figure 3.1) exhibit statistically significant differences in their extent of 
polymorphism, allele frequency spectra, extent of population differentiation, and 
haplotype homozygosity by comparing the patterns of nucleotide diversity (π), Tajima’s 
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D, FST, nSL, and H12 values across the four functional categories. 4 / 5 measures (π: 
Figure 3.7 & Additional Table 3.3a; Tajima’s D: Figure 3.3 & Additional Table 3.3b; FST: 
Figure 3.4 & Additional Table 3.3c; nSL: Figure 3.5a-c & Additional Table 3.3d-f) did not 
show significant differences among the four functional categories. In contrast, comparison 
of H12 values across the four functional categories showed significant differences 
between activation, transport, transfer and recognition (U-value = 114, adjusted p-value 
= 0.023; Figure 3.6 & Additional Table 3.3g) and between activation, transport, transfer 
and recycling, degradation (U-value = 23, adjusted p-value = 0.008; Figure 3.6 & 
Additional Table 3.3g). 
	
	
Figure 3.7. The distribution of nucleotide diversity values across the four functional 
categories of sialic acid biology genes. The graph presents the nucleotide diversity 
values calculated across all three ethnic groups. The 55 sialic acid biology genes are 
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displayed according to the functional categories they belong to. The nucleotide diversity 
value for each gene can be found in Additional Table 3.1. The number of genes belonging 
to each category is shown below the name of each functional category. 
 
Discussion  
In this study, we tested the hypothesis that loci involved in human sialic acid biology 
experienced recent positive selection by employing four population genetic tests designed 
to detect selective signatures at different time points during the evolution of modern 
humans. In all of our analyses, the majority of sialic acid biology genes did not significantly 
deviate from neutral expectations.  
 
One likely explanation of our results is that, for the most part, genes involved in sialic acid 
biology have not been targets of positive selection in the last 250,000 years of human 
evolution. Previous studies have shown that sialic acid biology genes were subject to 
strong ancient selective pressures that have resulted in species-specific adaptations 
(Varki 2001; Angata et al. 2004; Altheide et al. 2006; Varki and Gagneux 2009), 
suggesting that they likely evolved in response to ancient pathogens. The function of sialic 
acid biology genes, i.e., the generation of host-specific sialic acids and recognition of 
those self-associated molecular patterns (SAMPs) by cognate receptors, contributes to 
the detection of missing self (Medzhitov and Janeway 2002). It is possible that evolution 
of such markers of normal self, and the ability to recognize them correctly, have been 
influenced by ancient, but not, recent pathogens. For instance, the human-specific Alu-
mediated inactivation of CMAH, the protein product of which is responsible for generating 
Neu5Gc from its precursor Neu5Ac, has been suggested as a means of escaping 
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infection by Plasmodium reichenowi, a malaria-causing parasite that infects other great 
apes (Martin et al. 2005; Varki and Gagneux 2009). In addition, a human-specific mutation 
of an essential arginine residue required for sialic acid binding in Siglec-12 has been 
suggested to be evolutionarily related to the loss of Neu5Gc in humans (Varki 2009). 
Several other human-specific changes in sialic acid biology (e.g., deletion of SIGLEC13 
in humans or increased expression of SIGLEC1 on human macrophages compared to 
other primates) could have resulted from selective pressures exerted by paleopathogens 
(Varki 2009; Wang et al. 2012). It should be noted that several other innate-immunity 
genes have been shown to lack any signatures of positive selection in more recent 
evolutionary time scales (Mukherjee et al. 2009; Siddle and Quintana-Murci 2014).  
 
An alternative, but not mutually exclusive, possibility is that sialic acid biology genes may 
have experienced recent positive selection but – as the strength of selection can fluctuate 
over time and space – any signatures left from such selective episodes were not strong 
enough to alter the allele frequency spectra and extent of haplotype homozygosity of sialic 
acid biology genes within a single population or across multiple populations to detectable 
levels (Bell 2010; Pritchard et al. 2010). For example, even our most sensitive measure 
(the H12 index, which can discern past soft selective sweeps) is still biased towards 
detecting hard selective sweeps and loses power when sweeps are too soft (i.e., when 
selection has acted on numerous variants, resulting in a high number of haplotypes being 
present in the population) (Garud et al. 2015). Therefore, it is possible that signatures of 
selection left by very soft selective sweeps are not being detected by the methods 
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employed in this study. In addition, host defense is a complex biological process that 
involves interactions between numerous genes belonging to diverse biological pathways. 
As such, it is feasible that selection has operated not on individual sialic acid biology 
genes, but on the set of pathways that comprise sialic acid biology, resulting in only subtle 
changes in allele frequency spectra and haplotype homozygosity patterns of individual 
genes that could not be detected by the gene-specific tests employed in our study. The 
occurrence of such polygenic adaptation (Daub et al. 2013; Berg and Coup 2014; Daub 
et al. 2015) could similarly result in non-significant deviations from neutral expectations 
at the level of individual loci. 
 
Most of the sialic acid biology genes that did show evidence of recent positive selection 
were recovered by the haplotype-based H12 index (10 genes), with many fewer 
recovered by either the haplotype-based nSL (4-5 per population) or the two frequency 
spectra-based measures (Tajima’s D and FST; 2 each) (Figure 3.8). The key difference 
among these measures is that H12 has increased power to detect soft selective sweeps 
whereas the other three are designed to detect hard selective sweeps, suggesting that 
sialic acid biology genes likely experienced more soft than hard sweeps. This is consistent 
with a previous study suggesting that hard selective sweeps were likely rare during 
modern human evolution (Hernandez et al. 2011). Interestingly, genes that underwent 
hard selective sweeps were often involved in recognition of sialic acids, whereas genes 
that underwent soft sweeps were more often in the activation, transport, transfer and 
recycling, degradation categories (Figures 3.2 and 3.8). 	
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Figure 3.8. Few sialic acid biology genes have experienced both temporally and 
spatially varying modes of selective sweeps in recent human history 
 
We also found that the identity of the genes exhibiting significant deviations from neutral 
expectations was different among the various tests of selection employed in this study, 
and, in the case of nSL, among the three ethnic groups studied. The only overlap was for 
SIGLEC6, which was shown to exhibit significant values of both nSL (in Europeans) and 
H12. The lack of overlap likely reflects the differences in sensitivities of the four measures 
(see preceding paragraph), and hence the occurrence of spatially and/or temporally 
varying selective events. For instance, it has been demonstrated that tests that quantify 
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the extent of excess or depletion of rare alleles (e.g., Tajima’s D) have the most power to 
detect hard selective sweeps that happened at earlier time points, since the low rate of 
mutation in humans does not erase such signatures (Sabeti et al. 2006). Similarly, nSL 
has been shown to exhibit high power to detect signatures of selective sweeps that 
happened more recently and have resulted in only incomplete or partial fixation of alleles 
(Sabeti et al. 2006; Voight et al. 2007; Ferrer-Admetalla et al. 2014).   
 
In summary, considered jointly with previous evidence on the widespread occurrence of 
ancient positive selection on genes involved in sialic acid biology in hominids and 
hominins (Altheide et al. 2006; Angata et al. 2006; Varki and Gagneux 2009; Hayakawa 
and Varki 2011), these results support the hypothesis that human sialic acid biology 
genes bear many and strong evolutionary signatures of adaptation in response to ancient 
primate pathogens, but rather few and weak adaptive signatures in response to 
contemporary cosmopolitan or geographically-restricted human pathogens.  
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CHAPTER IV 
 
Signatures of recent positive selection in enhancers across 41 human tissues4,5 
 
Abstract 
Evolutionary changes in enhancers are widely associated with variation in human traits 
and diseases. However, studies comprehensively quantifying levels of selection on 
enhancers at multiple evolutionary time points during recent human evolution and how 
enhancer evolution varies across human tissues are lacking. To address these questions, 
we integrated a dataset of 41,561 transcribed enhancers active in 41 different human 
tissues (FANTOM Consortium) with whole genome sequences of 1,668 individuals from 
the African, Asian, and European populations (1000 Genomes Project). Our analyses 
based on four different metrics (Tajima’s D, FST, H12, nSL) showed that ~5.90% of 
enhancers considered showed evidence of recent positive selection and that genes 
associated with enhancers under positive selection are enriched for diverse immune-
related functions. The distributions of these metrics for brain and testis enhancers were 
often statistically significantly different compared to those of other tissues; the same was 
true for brain and testis enhancers that are tissue-specific compared to those that are 
tissue-broad and for testis enhancers associated with tissue-enriched and non-tissue-
enriched genes. These differences varied considerably across metrics and tissues and 
																																																						
4 This work is uploaded in https://www.biorxiv.org/content/10.1101/534461v1.  
5 The contributing authors are: Jiyun M. Moon, John A. Capra, Patrick Abbot, and 
Antonis Rokas. 
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were generally due to changes in distributions’ shapes rather than shifts in their values. 
These results suggest that many human enhancers experienced recent positive selection 
throughout multiple time periods in human evolutionary history, that this selection 
occurred in a tissue-dependent and immune-related functional context, and that much 
like the evolution of their coding counterparts, the evolution of brain and testis enhancers 
has been markedly different from that of enhancers in other tissues. 
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Introduction 
Enhancers are cis-acting DNA segments that, either independently of or in concert with 
other regulatory elements, control spatial, temporal and quantitative aspects of gene 
expression (Ong and Corces 2011; Rubinstein and de Souza 2013; Long et al. 2016). 
While the precise architecture of enhancers is still debated (Long et al. 2016), a typical 
enhancer contains multiple transcription factor binding sites (TFBS) arranged in specific 
order and distance from one another. Enhancers facilitate initiation of gene transcription 
by helping to recruit RNA Polymerase II, general transcription factors, and additional 
components of the transcriptional machinery to the gene’s promoter (Pennacchio et al. 
2013; Rubinstein and de Souza 2013). Multiple enhancers, each with its own repertoire 
of TFBS, can regulate the activities of a gene in a tissue-specific manner or across distinct 
developmental stages, enabling enhancers to alter its expression patterns in a particular 
context without affecting expression of other genes (Wray 2007; Sholtis and Noonan 
2010). Enhancers in the human genome are more numerous than protein-coding genes 
(Pennacchio et al. 2013), facilitating the induction of diverse gene expression programs 
in different spatial and temporal contexts (Long et al. 2016).  
 
Changes in gene regulation have long been thought to play a major role in the adaptive 
evolution of human traits (King and Wilson 1975; Carroll 2005). One reason for regulatory 
regions in general, and enhancers in particular, as preferential targets of selection is that, 
compared to protein-coding regions, they tend to be modularly organized (Sholtis and 
Noonan 2010). This modular organization means that mutations in enhancers are less 
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likely to have pleiotropic effects and more likely to contribute to phenotypic evolution 
(Carroll 2005; Wray 2007; Rebeiz and Tsiantis 2017). In the context of human evolution, 
several studies suggest that evolutionary changes in enhancers might have played a 
major role in the acquisition of human-specific traits. For example, a considerable 
proportion of regions that has experienced accelerated evolution in the human lineage 
are developmental enhancers active in the brain (Capra et al. 2013), and cis-regulatory 
regions of genes with neurological and nutritional roles have been shown to exhibit 
evidence of accelerated evolution in the human lineage (Rockman et al. 2005; Haygood 
et al. 2007). Accelerated evolution is one signature of positive selection, and several 
studies suggest that recent selection might also have preferentially acted on human cis-
regulatory regions (Wray 2007). For instance, Rockman et al. found that the promoter 
region of a gene that encodes the precursor of an opioid neuropeptide (PDYN) exhibits a 
significant degree of population differentiation between human populations, especially 
between Europeans and East Asians, which is suggestive of local adaptation (Rockman 
et al. 2005). Similarly, patterns of variation in the promoter region of the LCT gene that 
confers lactase persistence in Africans are consistent with the action of selective sweeps 
(Tishkoff et al. 2006). Finally, SNPs with evidence of recent positive selection are more 
likely to be associated with expression of nearby genes than random SNPs, and this 
enrichment is strongest for Yorubans (Kudaravalli et al. 2008).  
 
More broadly, genome-wide studies have found that, compared to protein-coding regions, 
enhancers are enriched for variants that are statistically associated with various human 
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diseases (e.g., inflammatory diseases, metabolic diseases) (Andersson et al. 2014; 
Karnuta and Scacheri 2018). Moreover, recent studies have argued that human 
population-level differences in transcriptional responses to infection likely resulted from 
local adaptation, further supporting the idea that selection on enhancers has contributed 
to recent human evolution (Nédélec et al. 2016). In addition, multiple events, such as 
migrations and shifts in cultural practices, have occurred in different time periods during 
recent human evolution (Karlsson et al. 2014), likely introducing novel selective agents. 
Given the role of enhancers in contributing to phenotypic differences, it is likely that 
enhancers experienced selection events in response to such selective pressures. 
 
Each human tissue serves a particular physiological function so it is reasonable to 
hypothesize that the genetic elements active in each tissue are influenced by distinct 
selective pressures that shape their evolutionary rates (Wray 2007; Gu and Su 2007). For 
example, both gene expression and protein-coding sequence divergence patterns might 
be expected to be more conserved in developmentally constrained tissues (e.g., nervous 
tissues) than in developmentally relaxed tissues (e.g., testis or endocrine tissues, such 
as pancreas). Alternatively, certain functions of tissues (e.g., reproductive processes for 
testis) might have experienced increased levels of positive selection (Khaitovich 2005). 
Early studies examining patterns of divergence in gene expression and protein-coding 
sequence evolution among mammals found that both were lowest for nervous tissues 
(e.g., brain, cerebellum) and greatest for testis (Wray 2007; Khaitovich 2005; Brawand et 
al. 2011). More recent examination of a larger number of human tissues has provided 
	 101	
further support for this hypothesis. For example, the correlation between expression 
levels of genes and the strength of purifying selection (as assessed by dN/dS) is strongest 
for the brain, while this correlation is lowest for liver, placenta and testis (Kryuchkova-
Mostacci and Robinson-Rechavi 2015).  
 
Hitherto, studies investigating the variation of evolutionary patterns among tissues have 
mainly focused on inter-species divergence of gene expression and of protein-coding 
sequences. However, studies comprehensively quantifying levels of selection on 
enhancers at multiple evolutionary time periods during recent human evolution and how 
enhancer evolution varies across human tissues are lacking. Furthermore, it is plausible, 
if not likely, that distinct selective pressures are also acting on regulatory elements in 
different tissues, further contributing to the global differences in gene expression patterns 
among the tissues described above (Ong and Corces 2011; Rubinstein and de Souza 
2013).  
 
To examine the influence of selection on enhancers at multiple evolutionary time periods 
during recent human evolution and how enhancer evolution varies across human tissues, 
we used a dataset of 41,561 enhancers active in 41 human tissues and genotype data of 
1,668 individuals from three different super-populations from the 1000 Genomes Project 
to calculate signatures of recent selection that happened at different time points and via 
different modes (i.e., hard vs soft selective sweeps). We found that on average, 5.90% of 
enhancers exhibit evidence of recent positive selection and that their putative target 
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genes are enriched for immunity-related functions. Furthermore, we found that enhancers 
expressed in the testis and brain exhibit statistically different patterns of recent evolution 
compared to numerous other tissues. Examination of patterns of recent evolution 
between enhancers that are active in only one tissue and those active in two or more 
tissues revealed statistically significant differences for several tissues, including brain and 
testis; we found similar results when we studied enhancers associated with tissue-
enriched and non-tissue-enriched genes in these two tissues. Our results suggest that 
human enhancers, in particular ones associated with immune-related genes, have 
experienced different modes of recent positive selection at different periods of recent 
human evolution. Furthermore, patterns of selection on human enhancers differ between 
tissues, including for brain and testis, a pattern reminiscent of their protein-coding 
counterparts.  
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Methods 
Genetic variation data 
To examine signatures of natural selection on human enhancers, we used the whole 
genome sequence data for 1,668 individuals from Phase 3 of the 1000 Genomes Project 
(The 1000 Genomes Project Consortium et al. 2015) (for information on data sources, 
see Additional File 4.1). The 1,668 individuals represent three major human populations 
(661 Africans, 503 Europeans, and 504 East Asians). We used these three populations 
because their demographic histories have been most confidently estimated and excluded 
the other two (Admixed Americans and South Asians) because their demographic 
histories are more complex. 
 
FANTOM enhancer data 
To study patterns of recent evolution on human enhancers active in different tissues, we 
used the enhancers detected in 41 human tissues compiled by the Functional Annotation 
of the Mammalian Genomes (FANTOM) project (Figure 4.1 & Additional File 4.1) 
(Andersson et al. 2014) based bidirectional transcription identified via cap analysis of 
gene expression (CAGE) in diverse human cell and tissue types (The FANTOM 
Consortium et al. 2014). We further classified the enhancers into ‘tissue-specific’ 
enhancers that are detected in only a single tissue, and ‘tissue-broad’ enhancers that are 
detected in two or more tissues. As genomic regions located on sex chromosomes exhibit 
patterns of genetic variation that differ from those observed in autosomal genomic regions 
(Schaffner 2004), we restricted our analyses to only autosomal enhancers. 	
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Figure 4.1. Visual summary of the FANTOM5 enhancer data set used in this study. 
Each circle represents a tissue and all 41 tissues are grouped into non-overlapping organ 
systems and are color-coded accordingly. The size of the circle is proportional to the log10 
of the number of enhancers active within each tissue (Additional Table 4.1: from highest 
to lowest: brain: 4,883, blood: 3,657, spleen: 2,429, lung: 2,366, thymus: 1,741, heart: 
1,737, testis: 1,621, meninx: 1,447, kidney: 1,294, large-intestine: 1,266, tonsil: 1,193, 
adipose-tissue: 1,161, spinal-cord: 1,115, eye: 1,019, blood-vessel: 982, small-intestine: 
880, uterus: 877, liver: 875, internal-male-genitalia: 846, esophagus: 845, thyroid-gland: 
795, skeletal-muscle: 784, throat: 782, placenta: 735, tongue: 708, female-gonad: 693, 
prostate-gland: 667, gallbladder: 654, urinary-bladder: 602, vagina: 512, salivary-gland: 
387, olfactory-region: 338, lymph-node: 292, smooth-muscle: 270, pancreas: 243, 
parotid-gland: 184, skin: 161, submandibular-gland: 159, penis: 154, umbilical-cord: 115, 
stomach: 92).   
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Human Protein Atlas data 
To compare the patterns of recent evolution between enhancers associated with genes 
that exhibit higher expression levels in one tissue compared to others and those that are 
not in our tissues of interest, the brain and testis, we downloaded the list of tissue-
enriched genes for the brain and testis tissues from the Human Protein Atlas database 
(Uhlen et al. 2015) (version 88; download date: January 17th, 2018): the Human Protein 
Atlas Database defines a gene as tissue-enriched if its mRNA levels in a given tissue are 
at least five-fold higher compared to its levels of expression in all other tissues. We 
defined ‘non-tissue-enriched’ genes as those genes that are not labeled as ‘tissue-
enriched’ according the to the Protein Atlas database. 
 
Identifying signatures of recent positive selection 
To identify signatures of recent positive selection on human enhancers, we calculated 
four metrics aimed to capture genetic signatures left from the action of selection at 
different time ranges during recent human evolution (Sabeti et al. 2006; Vitti et al. 2013; 
Moon et al. 2018) using previously described methodology (Moon et al. 2018). Briefly, the 
four metrics that we used can be divided into two categories: those that are designed to 
detect hard selective sweeps (Tajima’s D, Weir & Cockerham’s FST and nSL) and those 
designed to detect soft selective sweeps (H12). Furthermore, the three tests for hard 
selective sweeps are most sensitive to selection events that occurred at different time 
points in human history: Tajima’s D can detect selection that happened approximately 
250,000 - 200,000 years ago; FST can identify signatures of local selection that occurred 
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following the out-of-African migration approximately 75,000 - 50,000 years ago; finally, 
nSL has power to detect signatures left by selection events that occurred approximately 
20,000 - 10,000 years ago (Sabeti et al. 2006; Moon et al. 2018). Following the methods 
of Moon et al. (Moon et al. 2018) for each enhancer region in every tissue we calculated 
Tajima’s D using the R package PopGenome, version 2.1.6 (Pfeifer et al. 2014) and the 
weighted Weir & Cockerham’s fixation index (FST) (Weir & Cockerham 1984) among all 
three populations using VCFtools, version 0.1.13 (Danecek et al. 2011). In addition, we 
calculated the nSL statistic (number of segregating sites by length; (Ferrer-Admetlla et al. 
2014)) using Selscan, version 1.2.0 (Szpiech and Hernandez 2014). For each enhancer, 
we calculated nSL for the region extending 50 kilobases (kb) upstream and downstream 
using the default settings of Selscan, except for the minor allele frequency (MAF) cut-off 
value, for which we used 0.01. We calculated this metric for each of the three populations, 
as haplotype-based methods are known to detect selection events that occurred after the 
out-of-African migration (Voight et al. 2006; Sabeti et al. 2006). We used the maximum 
absolute un-standardized nSL values calculated over the entire window to represent each 
enhancer region. Finally, for each enhancer region we also calculated the H12 index 
using a custom script, based on Garud et al.’s original script (Garud et al. 2015). The 
values of all enhancers in the 41 human tissues for all metrics can be found in Additional 
File 4.4. 
 
To test for statistical differences in the distributions of each of the four metrics between 
any two tissues, we also carried out pairwise Kolmogorov-Smirnov tests (two-sided). 
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Visualization of the data (Additional Figure 4.1) revealed that assumptions of normality 
and equal variance could not be upheld, and therefore, we chose the non-parametric 
Kolmogorov-Smirnov test which makes no assumptions regarding the shape of the 
distributions and carried out this test in the R programming environment. We also 
conducted this test to examine whether there are any significant differences between the 
distributions of patterns of recent evolution between tissue-specific and tissue-broad 
enhancers, as well as between enhancers that are associated with tissue-enriched and 
non-tissue-enriched genes. All statistical tests were followed by post hoc Bonferroni 
corrections in R. The results of the statistical tests for all metrics can be found in Additional 
Tables 4.22-27, 28-33. 
 
Simulations of neutral evolution 
The action of non-adaptive processes and demographic changes, such as genetic drift 
and population expansion, can produce patterns of variation that these tests may mistake 
for positive selection (Sabeti et al. 2006). To determine the likelihood of the empirical 
values being generated by the action of selection, we carried out simulations of neutral 
evolution based on a model of recent human demographic history and compared the 
observed values to expected values under neutrality. Simulations of neutrality were 
conducted using SLiM, version 2.4.1 (Messer 2013; Haller and Messer 2017). Following 
Gravel et al., we used previously calculated demographic parameters for the three 
populations included in our study (Gravel et al. 2011; Messer 2013). Detailed information 
on the parameters used for the simulations can be found in the Additional File 4.1.  
	 108	
 
We simulated the genotypes of 661, 503, and 504 individuals corresponding to the 
numbers of individuals from each of the three populations analyzed. Since there are 
41,561 autosomal enhancers in the FANTOM dataset and anywhere from 92 (stomach) 
to 4,883 (brain) enhancers in any given tissue (Additional Table 4.1), carrying out 
individual simulations for each enhancer was computationally prohibitive. To reduce the 
computational load of our simulations, we focused on simulating the mutational profile of 
an average enhancer for a given tissue under a model of neutral evolution. Specifically, 
to carry out the neutral simulations for enhancers in a given tissue, we used the average 
length of all the autosomal enhancers found in that tissue (Additional File 4.2) and a fixed 
recombination rate of 1x10-8. For each tissue, we carried out 10,000 simulations. We next 
used these simulated sequences to calculate Tajima’s D values, Weir & Cockerham’s 
FST, and H12 as described above. We calculated an empirical p-value for a given 
enhancer for any metric (including for nSL, the simulation process of which is described 
below) as the proportion of simulated sequences that obtained scores equal to or more 
extreme than the observed value. We used a p-value of 0.05 as cutoff for significance; 
enhancers with p-values lower than 0.05 were considered to significantly deviate from 
neutral evolution and to have experienced selection.  
 
Recombination rate interpolation and simulation of nSL values 
As variation in recombination rates can affect the values of nSL (Ferrer-Admetlla et al. 
2014), we carried out a separate set of neutral simulations for the calculation of nSL values 
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by incorporating average recombination rates for each tissue. To do this, we used the 
genome-wide genetic map  curated by the HapMap II consortium (Frazer et al. 2007), 
which provides pre-computed recombination rates (cM/Mb) for the variants included in 
the HapMap II project. More specifically, we carried out linear interpolation to infer the 
recombination rates of the variants in the 1000 Genomes Project dataset that are not 
included in the HapMap Phase II dataset. Next, we calculated the average recombination 
rate (cM/Mb) for the region spanning 50 kb up and downstream of each enhancer in a 
given tissue, and then used the average of all recombination rates of the enhancer regions 
in a given tissue as the recombination rate parameter (converted to probability of 
crossovers per bp) for the neutral simulations. The average recombination rates, as used 
in our SLiM simulations, for each tissue can be found in Additional File 4.3. Using these 
calculated recombination rates, we then created 2,500 enhancers that span 50 kb 
upstream and downstream of the average length of all autosomal enhancers found in that 
given tissue and calculated nSL values on these simulated enhancers using Selscan as 
described above. As with the actual enhancers, we only included variants with MAF 
greater than 0.01 in the calculations and used the maximum absolute un-standardized 
values to represent a given simulated window. 
 
Functional enrichment analyses and semantic similarity calculations 
To gain insight into the functions of genes associated with enhancers that show evidence 
of selection, we next carried out functional enrichment analyses. To associate enhancers 
with putative target genes, we used the transcription start site (TSS)-enhancer mapping 
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file generated by Andersson et al. (Andersson et al. 2014) (file location information can 
be found in Additional File 4.1), which was compiled by measuring the pairwise correlation 
between enhancer activity and transcription level of putative target genes. We carried out 
functional enrichment analyses on the list of these putative target genes using the R 
package TopGO, version 2.32.0 (Alexa and Rahnenfuhrer 2016). Detailed description of 
the files and commands used can be found in Additional File 4.1. In short, we used the 
‘weight’ algorithm that compares the significance scores of the connected nodes to 
explicitly account for the hierarchy of the gene ontology tree and carried out analyses for 
the three general ontologies: Biological Process (BP), Molecular Function (MF), and 
Cellular Component (CC). Subsequent corrections for multiple comparisons were carried 
out by calculating the FDR-adjusted p-values in the R statistical environment; only those 
GO terms with an FDR-adjusted p-value less than 0.05 were retained for further analyses. 
All TopGO enrichment analysis results for all the metrics can be found in Additional Files 
4.5-21. 
 
To quantify the overall similarity of the patterns of gene functional enrichment among 
different tissues, we calculated pairwise semantic similarity of the GO terms between any 
two tissues using a graph-based method (Wang et al. 2007), which takes into 
consideration the topology of the GO graph structure (i.e., the location of the GO terms in 
the graph and the relationship of the terms to their ancestor terms), as implemented in 
the R package GOSemSim, version 2.4.1 (Yu et al. 2010): this analysis was carried out 
for only those tissues that have 5 or more significant GO terms. To determine if the 
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semantic similarity scores thus calculated significantly deviated from random 
expectations, we randomly sampled the same number of GO terms for each tissue from 
the pool of all GO terms associated with a given tissue 1,000 times and calculated the 
pairwise semantic similarity score; scores equal or greater than the 95th percentile value 
of the distribution of semantic similarity scores were considered significant. The 
calculated semantic similarity values, along with the 95th percentile values obtained from 
the 1,000 randomly sampled GO terms for each tissue pair, can be found in Additional 
Tables 4.7-15. 
 
Transposable element (TE) data and analyses 
TE-derived sequences often contribute to the origin of new enhancers and the 
modification of regulatory networks (Lynch et al. 2015; Simonti et al. 2017). To determine 
if the enhancers with evidence of recent positive selection harbor higher proportions of 
TEs than those with nonsignificant deviations from neutral expectations, we used 
BEDOPS, version 2.4.35 (Neph et al. 2012) to overlap the enhancer regions with the 
RepeatMasker-annotated regions. We downloaded the RepeatMasker annotation track 
for the hg19 assembly from the UCSC Genome Browser (Kent et al. 2002; Casper et al. 
2018; Raney et al. 2014). The location of the RepeatMasker annotation file and the 
specific commands used for BEDOPS can be found in Additional File 4.1. To test for 
statistical differences in the proportions of TEs between enhancers with evidence of 
recent selection and those that do not exhibit such significant deviation from neutral 
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expectations, we carried out a 2x2 chi-squared test with Yate’s continuity correction using 
R. The results of the chi-squared tests can be found in Additional Tables 4.16-21. 
 
GWAS catalog data annotation  
Previous studies have shown that many variants in human cis-regulatory regions are 
significantly associated with a broad range of complex traits and diseases (Lee and 
Young 2013; Andersson et al. 2014; Karnuta and Scacheri 2018). To investigate whether 
brain and testis enhancers that exhibit evidence of recent positive selection show 
enrichment of variants in the Genome-Wide Association Study (GWAS) catalog, we 
downloaded the NHGRI-EBI GWAS catalog, version1.0.2 (MacArthur et al. 2017) 
(download date: June 2nd, 2018) and first compared the SNPs that reside in the enhancer 
regions with GWAS catalog SNPs. We also included SNPs that are outside the enhancer 
regions but in complete linkage disequilibrium (LD) with the SNPs within the enhancer 
regions. We used Plink, version 1.0.9 (Chang et al. 2015) to obtain a list of SNPs that are 
in complete LD (r2 = 1.0) with those that lie within the enhancers of interest (‘complete LD 
SNPs’) and carried out the same analyses as described above. Detailed description of 
the Plink analyses can be found in Additional File 4.1. For subsequent analyses, we 
combined the GWAS hits of the SNPs that reside within the enhancers and those that are 
in complete LD with SNPs inside the enhancers and considered them together. We also 
carried out the same analyses for brain and testis enhancers that exhibit nonsignificant 
deviations from neutral expectations. To determine if there is a statistical difference in the 
enrichment of variants in the GWAS hits between enhancers that exhibit evidence of 
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recent positive selection and those that do not, we carried out 2x2 chi-squared tests with 
Yate’s continuity correction using R. The full list of all the GWAS hits that overlap with all 
the variants considered, as well as the chi-squared test results, can be found in Additional 
Tables 4.36-37 and 4.38-39. 
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Results 
Enhancers experienced positive selection at different time ranges during recent 
human history 
Calculation of four metrics of selection (Weir & Cockerham’s FST, Tajima’s D, H12 and 
nSL) for all 41,561 enhancers in 41 tissues (Additional File 4.4) revealed that an average 
5.90% of enhancers have experienced recent positive selection considering all metrics 
and tissues (Figure 4.2). The proportions of enhancers that exhibit significant deviations 
from neutral expectations for each metric varied (Figure 4.2; Additional Table 4.2). 
Specifically, greater fractions of enhancers show evidence of recent positive selection 
according to H12 and Tajima’s D metrics (H12: from 6.57% to 16.67%; Tajima’s D: 6.75% 
to 13.92%) than other metrics (FST: 1.91% to 5.56%; nSL in Africans: 1.12% to 7.08%; 
nSL in Europeans: 2.25% to 5.39%; nSL in East Asians: 2.25% to 5.93%). Furthermore, 
for 33/41 tissues examined, the H12 metric had the highest proportion of enhancers 
exhibiting evidence of recent selection. These results imply that human enhancers 
experienced selection at different time points in human history, with substantial evidence 
for soft selective sweeps in which multiple haplotypes increase in frequency within a 
population (Pennings and Hermisson 2006; Messer and Petrov 2013). However, we 
caution against overly interpreting differences in the proportions of enhancers across 
metrics as differences in the action of selection across different time periods since they 
likely vary in power to detect selection. 
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Figure 4.2. Proportions of enhancers exhibiting significant deviations from neutral expectations for different recent 
positive selection metrics across 41 tissues. Each dot represents the proportion of enhancers (Y-axis) that exhibited 
significant deviation from the neutral model (i.e., p-value < 0.05) in a given tissue (X-axis). Differently colored dots 
correspond to the different selection metrics used (Salmon: Tajima’s D; Teal: FST; Green: H12; Blue Gray: nSL (Africans); 
Orange: nSL (Europeans); Purple: nSL (East Asians)). For each metric, the p-value for the observed value for an enhancer 
(i.e., the likelihood under neutral expectations of obtaining a value as or more extreme as the observed 
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value) was assessed by comparing to 10,000 simulated values calculated on sequences 
generated from the neutral simulations. Differently colored horizontal lines correspond to 
the average of all proportions calculated for all 41 tissues according to the different 
selection metrics used (Salmon: Tajima’s D; Teal: FST; Green: H12; Blue Gray: nSL 
(Africans); Orange: nSL (Europeans); Purple: nSL (East Asians)). Note the 1) differences 
in the proportion of enhancers exhibiting significant deviations from neutral expectations 
across tissues in any given metric, and 2) similarly, differences in the proportion of 
enhancers with significant deviations from the neutral model across all metrics in any 
given tissue.   
	
Enhancers that exhibit evidence of recent positive selection putatively regulate the 
activities of genes with immunity-related functions 
To study the functions of the enhancers that show evidence of recent positive selection, 
we carried out enrichment analysis on the putative target genes associated with them 
(these results can be found in the Additional Files 4.5-21). We found that there was little 
functional enrichment among the enhancers identified by FST, Tajima’s D and H12 (Table 
4.1). However, many tissues had multiple significant enriched GO terms among the nSL 
hits (Table 4.1). For the FST, Tajima’s D and H12 metrics, we also collapsed all enhancers 
irrespective of their tissues and carried out the same analyses: we found similar patterns 
as described above, with no significant GO terms for the FST metric and very few GO 
terms for Tajima’s D and H12 metrics (Additional Tables 4.3-6). The majority of top 10 
most frequent significant GO terms among all tissues for the nSL metric were immunity-
related (Tables 4.2-4.4). In addition, we also carried out the same analyses on the putative 
target genes of enhancers with no evidence of recent positive selection according to the 
nSL metric and found that none of the tissues possessed any significantly enriched GO 
terms: the only exception was a single Cellular Component term in the parotid-gland for 
nSL metric in Europeans (GO:0044444: cytoplasmic part, adjusted p-value = 0.047). 
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These results suggest that approximately 20,000–10,000 years ago, enhancers that 
putatively regulate the activities of immunity-related genes in multiple tissues underwent 
selection, a finding consistent with the hypothesis that human populations faced novel 
local selective pressures as they moved into new environments (Balaresque et al. 2007; 
Fumagalli et al. 2011).  
 
Table 4.1 Number of tissues with one or more significantly enriched GO terms 
Metric # of Biological Process GO terms 
# of Molecular 
Function GO 
terms 
# of Cellular 
Compartment GO 
terms 
Tajima’s D 4 2 4 
FST 2 2 2 
H12 0 1 1 
nSL (AFR) 18 18 18 
nSL (EUR) 20 20 19 
nSL (EAS) 19 19 19 
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Table 4.2. Most frequently-occurring GO terms among enhancers with evidence of recent positive selection by nSL 
across tissues in Africans 
 
BP GO Terms # of tissues MF Go Terms # tissues CC GO Terms # of tissues 
Antigen processing 
and presentation of 
exogenous peptide 
antigen 
18 MHC class II receptor activity 18 
trans-Golgi network 
membrane 18 
T cell co-stimulation 18 
MHC class II 
protein complex 
binding 
18 
Integral component of 
luminal side of endoplasmic 
reticulum membrane 
18 
interferon-gamma-
mediated signaling 
pathway 
17 Peptide antigen binding 15 Endosome membrane 18 
T cell receptor 
signaling pathway 16 TAP1 binding 13 
ER to Golgi transport 
vesicle membrane 17 
Antigen processing 
and presentation of 
exogenous peptide 
antigen via MHC 
class I TAP 
dependent 
15 
Peptide antigen-
transporting 
ATPase activity 
12 Lysosomal membrane 16 
MHC class II protein 
complex assembly 14 TAP2-binding 10 TAP complex 14 
    MHC protein complex 11 
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Table 4.3. Most frequently-occurring GO terms among enhancers with evidence of recent positive selection by nSL 
across tissues in Europeans 
 
BP GO Terms # of tissues MF GO Terms # of tissues CC GO Terms # of tissues 
Interferon gamma-
mediated signaling 
pathway 
18 MHC class II receptor activity 18 
Integral component of luminal 
side of endoplasmic reticulum 
membrane 
19 
Antigen processing 
and presentation of 
exogenous peptide 
antigen 
17 
MHC class II 
protein complex 
binding 
18 ER to Golgi transport vesicle membrane 18 
T cell co-stimulation 17 Peptide antigen binding 15 trans-Golgi network membrane 18 
T cell receptor 
signaling pathway 14 TAP1 binding 14 Endosome membrane 17 
MHC class II protein 
complex assembly 13   Lysosomal membrane 15 
    Endocytic vesicle membrane 12 
    TAP complex 12 
    MHC protein complex 12 
 
 
 
 
 
 
 
 
	 120	
Table 4.4. Most frequently-occurring GO terms among enhancers with evidence of recent positive selection by nSL 
across tissues in East Asians 
 
BP GO Terms # of tissues MF GO Terms # of tissues CC GO Terms # of tissues 
Antigen processing 
and presentation of 
exogenous peptide 
antigen  
17 Peptide antigen binding 19 
Integral component of luminal 
side of endoplasmic reticulum 
membrane 
19 
T cell co-stimulation 17 MHC class II receptor activity 18 trans-Golgi network membrane 18 
interferon-gamma-
mediated signaling 
pathway 
16 
MHC class II 
protein complex 
binding 
18 Lysosomal membrane 18 
T cell receptor 
signaling pathway 15 TAP1 binding 12 
ER to Golgi transport vesicle 
membrane 17 
MHC class II protein 
complex assembly 14   Endocytic vesicle membrane 16 
Antigen processing 
and presentation of 
exogenous peptide 
antigen via MHC 
class I TAP 
dependent 
11   TAP complex 12 
    Endosome membrane 10 
    MHC II protein complex 10 
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We also quantified the semantic similarity (SS) of the functionally enriched terms among 
the tissues to determine if the pattern of enrichment for immunity-related functions was 
shared across tissues (Additional Figures 4.2a-i). The pairwise SS values calculated 
using the TopGO GO terms associated with the nSL metrics were consistently very high 
(BP: Africans: 0.687 to 1.000; Europeans: 0.786 to 1.000; MF: Africans: 0.779 to 1.000; 
Europeans: 0.715 to 1.000; East Asians: 0.902 to 1.000; CC: Africans: 0.873 to 1.000; 
Europeans: 0.864 to 1.000; East Asians: 0.853 to 1.000): one exception to this general 
trend were the SS scores calculated on the Biological Process terms in East Asians (from 
0.208 to 1.000) (Additional Figure 4.2c). To determine if the range of SS values we 
observed were unusually high, we compared each pairwise SS value to the 95th percentile 
value of the SS values calculated on the 1,000 randomly sampled GO terms for the same 
pair of tissues (these values, as well as the empirical SS values, can be found in 
Additional Tables 4.7-15). We found that most of the empirical SS values were higher 
than the 95th percentile values of the SS values calculated on the randomly sampled GO 
terms, with the exception of pairwise comparisons involving liver for the Biological 
Process terms in East Asians (Additional Figure 4.2c). In other words, most pairs of 
tissues were associated with semantically similar GO terms, suggesting that patterns of 
functional enrichment were very similar across tissues. The sole exception to this were 
13 comparisons involving the liver, which had three additional biological terms in East 
Asians (GO:0071294: cellular response to zinc ion, adjusted p-value = 0.005; 
GO:0046597: negative regulation of viral entry into host cell, adjusted p-value = 0.005; 
GO:007126: cellular response to cadmium ion, adjusted p-value = 0.014), which were 
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found only in the liver. Overall, our analyses suggest that the enrichment for immunity-
related functions found in putative target genes of enhancers with evidence of recent 
positive selection is not confined to specific tissues, but represents a general trend. 
 
Enhancers that exhibit evidence of recent positive selection are not enriched for 
transposable element origins 
To examine whether enhancers that exhibit statistically significant signatures of recent 
positive selection tend to have arisen from TEs, we compared the proportions of TE 
overlap between enhancers that exhibit evidence of recent positive selection versus 
enhancers with no evidence of recent positive selection across all 41 tissues. Of the 41 
tissues examined, only the lung (c2 = 12.859, adjusted p-value = 0.002) and the female 
gonad (c2 = 8.632, adjusted p-value = 0.020) displayed statistically significant differences 
in terms of the proportions of TE-overlapping regions between the two groups of 
enhancers for the H12 metric (Additional Figures 4.3a-f). Moreover, in these two tissues, 
enhancers with evidence of recent positive selection showed lower proportions of TE 
overlap than enhancers with no such evidence. Overall, these results suggest that 
enhancers that have arisen from TEs were not preferential targets of recent positive 
selection.  
 
Enhancers active in testis and brain show different patterns of recent evolution 
To test the hypothesis that signatures of selection during recent human history differed 
across enhancers active in different tissues, we compared the distributions of the four 
	 123	
metrics across all 820 pairs of the 41 tissues (these results can be found in Additional 
Tables 4.22-27). The number of tissue pairs exhibiting different distributions for Tajima’s 
D was 22 / 820, for FST was 5 / 820, for H12 was 56 / 820, and for nSL was 2 / 820 in 
Africans, and 0 / 820 in Europeans and East Asians (Figures 4.3a-f). All tissue pairs 
exhibiting significantly different distributions involved either brain or testis, with the 
exception of two nSL comparisons (Africans: Adipose-tissue and Large-intestine: p-value 
= 0.014; Adipose-tissue and Thymus: p-value = 0.007). Specifically, brain enhancers 
exhibited significantly different distributions for Tajima’s D, FST, and H12 compared to 
enhancers from 5, 2, and 23 other tissues (Figures 4.3a-c); similarly, testis enhancers 
exhibited significantly different distributions for Tajima’s D, FST and H12 compared to 
enhancers from fifteen, three, and thirty other tissues (Figures 4.3a-c). We note that the 
high fractions of enhancers under selection in brain and testis are unlikely to be solely 
due to the high number of enhancers found in these tissues; specifically, there are several 
other tissues that have high number of enhancers (Additional Table 4.1) and yet fail to 
exhibit statistically significant pairwise comparisons with other tissues. 
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Figure 4.3. Pairwise comparisons of the patterns of recent evolution among 
enhancers from 41 tissues. Each graph shows the results of the pairwise Kolmogorov-
Smirnov tests carried out between all pairs of 41 tissues (shown on the X- and Y-axes) 
for all recent positive selection metrics. Each cell represents a pairwise comparison 
between two specific tissues: red-filled cells represent pairwise comparisons that are 
statistically significant (i.e., adjusted p-value < 0.05) and empty cells represent non-
significant pairwise comparisons.   
 
In general, the significant differences in the distributions of these metrics between testis 
or brain and other tissues were due to differences in the magnitude of the peaks of the 
distributions and/or differences in shapes of the distributions rather than from shifts in the 
range of the distributions. For all metrics, most pairs of tissues with significant differences 
had very subtle shifts in the distributions, and in cases where the shifts were more 
noticeable, brain and testis enhancers’ distributions tended to be shifted to the left (for 
FST; Additional Figure 4.5) or the right (for Tajima’s D; Additional Figure 4.4), both in the 
direction suggestive of lower levels of positive selection. The nature of the differences in 
the peaks of the magnitude varied for each metric: for FST, the peaks for both brain and 
testis were consistently higher compared to those of the other tissues. In contrast, for 
Tajima’s D, the peaks for brain and testis were consistently lower than the other tissues 
being compared; the sole exception was the comparison between brain and meninx and 
urinary-bladder, in which the peaks were almost equal or slightly higher for the brain, 
respectively. In addition, for Tajima’s D, there were differences in the shapes of the 
distribution (Additional Figure 4.4). For H12, differences in the shape of the distributions 
also contributed to the statistical differences we observed between brain or testis and 
other tissues (Additional Figures 4.6-7). These results imply that enhancers active in the 
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brain and testis experienced different selective pressures during recent human history 
compared to enhancers active in other tissues. 
 
We also ranked the tissues according to the median values of each metric (Additional 
Figure 4.8) and the proportion of enhancers that exhibit statistically significant evidence 
of recent positive selection for each metric (Additional Figure 4.9). Overall, we did not find 
any general patterns regarding the recent evolution of brain and testis, in terms of either 
the median values of the metrics of recent selection (Additional Figure 4.8) or the 
proportion of enhancers that have putatively been under selection (Additional Figure 4.9). 
Exceptions to the general trend were that testis and brain ranked 1st and 2nd, respectively, 
for median values of the H12 metric (Additional Figure 4.8c) and that testis ranked 2nd in 
the proportion of enhancers with evidence of recent selection according to Tajima’s D and 
nSL in Africans (Additional Figures 4.9a & d).  
 
Evolution of tissue-specific enhancers differs from that of tissue-broad enhancers 
in the brain and testis 
We next compared the patterns of recent evolution between tissue-specific and tissue-
broad enhancers for each tissue. We found that the number of tissues with statistically 
significant differences in the distributions of the metrics between enhancers active in a 
single tissue and those active in multiple tissues was as follows, sorted from highest to 
lowest: 20/41 for H12, 8/41 for Tajima’s D, 8/41 for FST and 1/41 for nSL in Africans and 
East Asians (Figure 4.4a & Additional Figures 4.10-15). Tissue-specific and tissue-broad 
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enhancers in the brain and testis show statistically significant differences in the patterns 
of recent evolution for all metrics except nSL (Tajima’s D: brain: 1.882e-07; testis: 9.523e-
11; FST: brain: 6.074e-07; testis: 1.639e-07; H12: brain: < 2.2e-16; testis: < 2.2e-16 
(Figures 4.4b-d). Regarding the nature of the differences between the two groups of 
enhancers in these tissues, we found contrasting patterns for H12 compared to Tajima’s 
D and FST: for Tajima’s D and FST, we found that the interquartile values of the tissue-
specific enhancers were lower (or higher for Tajima’s D) than those of the tissue-broad 
enhancers in brain and testis, whereas those values were consistently higher for the 
tissue-specific enhancers compared to the tissue-broad enhancers in the same tissues 
for the H12 metric. These results suggest that, in general, enhancers with different 
breadth of tissue activity did not differ in their patterns of recent evolution. Nevertheless, 
enhancers active only in the brain do show significant differences compared to those 
active in multiple tissues (including brain) and the same is true for testis, raising the 
possibility that the recent evolution of brain- and testis-specific enhancers may have been 
different from that of other tissue-specific enhancers. 
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Figure 4.4. The recent evolution of testis enhancers associated with tissue-enriched genes differs from the 
evolution of enhancers associated with non-tissue-enriched genes. (a) The grid panel depicts which tissues exhibit 
significantly different distributions of metrics between tissue-specific and tissue-broad enhancers. Each cell represents a  
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comparison between tissue-specific and tissue-broad enhancers in a given tissue: pink-
filled cells represent the comparisons that are statistically significant (i.e., adjusted p-
value < 0.05) and empty cells represent non-significant comparisons. (b–d) Violin plots 
depicting the distributions of the metrics for tissue-specific and tissue-broad enhancers 
for brain and testis for (b) Tajima’s D, (c) Weir & Cockerham’s FST, and (d) H12. In all 
cases, the distributions of tissue-specific and tissue-broad enhancers were significantly 
different (see also panel a). 
 
The recent evolution of testis enhancers associated with tissue-enriched genes 
differs from the evolution of enhancers associated with non-tissue-enriched genes 
To determine whether there are differences in the patterns of recent evolution between 
enhancers associated with tissue-enriched genes versus those associated with non-
tissue-enriched genes, we compared the distributions of the four metrics between brain 
and testis enhancers stratified by the breadth of expression of their target genes (these 
results can be found in Additional Tables 4.34-35). There were significant differences for 
H12 (adjusted p-value = 3.667e-06) and Tajima’s D (adjusted p-value = 0.004) in the 
testis (Figure 4.5a-b). More specifically, we found that the distribution of Tajima’s D values 
of the enhancers associated with testis-enriched genes were shifted to the left (i.e., more 
negative values) compared to the enhancers associated with non-testis-enriched genes 
(Figure 4.5a). The difference between the same groups of enhancers for the H12 metric 
was comparatively subtle, with the main difference being the magnitude of the peak 
(Figure 4.5b); the peak of the distribution of the enhancers associated with the non-testis-
enriched genes was higher than that of the enhancers associated with testis-enriched 
genes. In contrast, there were no significant differences in the distributions of FST and nSL 
values between these two categories of enhancers for either tissue and the distributions 
of H12 and Tajima’s D between the same categories of enhancers for the brain (Figure 
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4.5). These results imply that enhancers associated with genes with enriched expression 
in the testis have experienced different degrees of selection in the form of both hard and 
soft selective sweeps compared to enhancers associated with genes that do not show 
enriched expression in the same tissue.
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Figure 4.5. Comparisons of patterns of recent evolution between enhancers associated with tissue-enriched genes 
and enhancers associated with non-tissue-enriched genes in brain and testis. The violin plots depicting the 
distributions of the metrics for enhancers associated with tissue-enriched and non-tissue-enriched genes for brain and testis 
for: (a) Tajima’s D (b) Weir & Cockerham’s FST (c) H12 (d) nSL (Africans) (e) nSL (Europeans) (f) nSL (East Asians). Plots 
with asterisks above them indicate significant pairwise comparisons.  
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Brain and testis enhancers under recent positive selection are not significantly 
enriched for variants associated with complex human traits and diseases 
To examine if genetic variants in brain and testis enhancers showing signatures of recent 
selection are associated with particular complex human traits and diseases, we queried 
the NHGRI-EBI GWAS catalog (MacArthur et al. 2017). We found that for all metrics, 
most or all enhancers did not harbor SNPs that are associated with any human traits 
(brain: Tajima’s D: 372/421; FST: 131/150; H12: 430/437; nSL(Africans): 150/167; nSL 
(Europeans): 144/161; nSL (East Asians): 152/170; testis: Tajima’s D: 143/163; FST: 47/52; 
H12: 102/103; nSL (Africans): 64/72; nSL (Europeans): 48/54; nSL (East Asians): 60/65). 
In the few instances in which SNPs within enhancers showing evidence of selection were 
associated with human traits, these associations were with traits such as Alzheimer’s 
disease (brain: Tajima’s D), obesity-related traits (brain: Tajima’s D), and type 2 diabetes 
(brain: nSL (Africans)) (Tables 4.5 & 6; the full list of overlapping GWAS hits, including 
variants in LD with those inside enhancers, can be found in Additional Files 4.36-37). We 
next compared the proportions of enhancers that overlapped with GWAS hits between 
enhancers that exhibit evidence of recent positive selection and enhancers that do not 
and did not find any significant difference between them. More specifically, we saw no 
statistically significant differences in the proportions of overlap with GWAS hits between 
enhancers with or without evidence of recent positive selection: the only exception was 
the H12 metric in the brain (c2= 30.552, adjusted p-value = 1.950e-07), which showed 
depletion of GWAS hits among enhancers with evidence of recent positive selection 
(These results can be found in Additional Tables 4.38-39). These results show that overall, 
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enhancer SNPs under recent positive selection are not preferentially associated with 
specific human traits or complex human diseases.  
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Table 4.5. Complex human traits and diseases associated with variants within the brain enhancers that exhibit 
evidence of recent selection 
 
Enhancer ID rsID Traits Metrics 
chr2:219271996-219272374 rs921968 Mean corpuscular  
hemoglobin concentration 
FST 
chr3:181418145-181418802 rs34308817 Ankle injury Tajima’s D 
chr6:30069810-30070038 rs1111180 Eosinophil percentage of granulocytes, Eosinophil 
percentage of white cells 
nSL (EUR) 
chr6:30923441-30923743 rs17189763 Conotruncal heart defects  
(maternal effects) 
nSL (EUR) 
chr6:32427743-32428120 rs9268831 Response to hepatitis B vaccine nSL (AFR, 
EUR, EAS) 
chr6:32427743-32428120 rs9268835 Type 2 diabetes nSL (AFR, 
EUR, EAS) 
chr6:32577297-32577935 rs660895 IgA nephropathy, Rheumatoid arthritis, Rheumatoid 
arthritis (ACPA-negative) 
nSL (AFR, 
EUR, EAS) 
chr7:130720133-130720826 rs10265693 Lung cancer FST 
chr7:29217860-29218383 rs245914 Psychosis (atypical), 
Obesity-related traits 
Tajima’s D 
chr13:110790027-110791241 rs641862 Obesity-related traits Tajima’s D 
chr16:22201170-22202123 rs145049847 Alzheimer disease and age of onset Tajima’s D 
chr16:87856343-87856555 rs76069656 Triglyceride change in response to fenofibrate in statin-
treated type 2 diabetes 
nSL (EUR) 
chr16:87886258-87886670 rs68149176 Mean corpuscular volume, 
Mean corpuscular hemoglobin 
nSL (EUR), 
FST 
chr21:45616099-45616530 rs4456788 Chronic inflammatory diseases (ankylosing spondylitis, 
Crohn's disease, psoriasis, primary sclerosing 
cholangitis, ulcerative colitis)  
(pleiotropy) 
nSL (EAS) 
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Table 4.6. Complex human traits and diseases associated with variants within the testis enhancers that exhibit 
evidence of recent selection 
 
Enhancer ID rsID Traits Metrics 
Chr6:30069810-30070038 rs1111180 Eosinophil percentage of granulocytes, Eosinophil percentage of white cells 
nSL 
(Europeans) 
Chr6:30923441-30923743 rs17189763 Conotruncal heart defects  (maternal effects) 
nSL 
(Europeans) 
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Discussion 
In this study, we calculated four different metrics that detect distinct genomic signatures 
of recent selection on the enhancers active in 41 human tissues and compared the 
empirical values of these metrics to those calculated on neutrally simulated sequences. 
We found that across all tissues and metrics, approximately 5.90% of enhancers exhibit 
significant evidence of recent positive selection. We also found that the putative target 
genes of such enhancers are enriched for immunity-related functions, and that this 
enrichment pattern is shared across multiple tissues. Furthermore, enhancers active in 
the brain and testis exhibited significantly different patterns of recent evolution compared 
to enhancers in other tissues.  
 
Across tissues, we observed variation in the proportions of enhancers that exhibited 
signatures of selection across the different metrics (Figure 4.2). Since the origin of 
modern humans approximately 250,000 - 200,000 years ago, there have been multiple 
distinctive events in human history, including the out-of-Africa migration approximately 
75,000 - 50,000 years ago, the Eurasian split that occurred approximately 45,000 - 36,000 
years ago, and the Agricultural Revolution approximately 20,000 - 10,000 years ago, all 
of which would have likely exposed the human populations to novel selective pressures 
(e.g., pathogens, dietary changes) (Sabeti et al. 2006; Karlsson et al. 2014). Adaptations 
in response to such changes would have likely altered the allele frequencies in both the 
genic and regulatory regions. Furthermore, it has been previously shown that different 
metrics of selection are sensitive to distinct types of genomic signatures (Sabeti et al. 
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2006; Voight et al. 2006). For example, Tajima’s D is most suitable for detecting events 
that occurred approximately 250,000 - 200,000 years ago, FST is most suitable for 
identifying selection events that occurred as humans left Africa and were exposed to 
novel environments around the world (i.e., 75,000 - 50,000 years ago), whereas nSL is 
most suitable for detecting selection events that happened approximately 20,000 - 10,000 
years ago (Sabeti et al. 2006; Voight et al. 2006). Therefore, one possible interpretation 
is that within any given tissue, the differences in percentages of enhancers under 
selection between metrics reflect temporal variation in the action of selection during 
human history.  
 
While the variation in the proportion of enhancers with significant evidence of recent 
selection across different metrics could represent temporal variation in the action of 
selection, it is also likely that these metrics have different power to detect selection. For 
instance, Tajima’s D, a metric that detects excess of rare alleles in a region of interest, 
has been shown to be most sensitive to selective sweeps that have resulted in almost 
complete fixation (i.e., allele frequencies = 100%) of the target locus and conversely has 
limited power to detect actions of selection that have resulted in incomplete fixation of the 
allele (Sabeti et al. 2006; Ferrer-Admetlla et al. 2014). In contrast, nSL, a haplotype-based 
metric, best detects ongoing or incomplete hard selective sweeps resulting in 
intermediate allele frequencies (i.e., allele frequencies = 60 - 80%) and rapidly loses 
power as allele frequencies increase to 100% (Ferrer-Admetlla et al. 2014). Thus, the 
observed differences in the proportions of enhancers with evidence of recent positive 
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selection across the metrics also reflect the disparity in power of the metrics to 
successfully detect incidences of selection that happened at a particular time period. 
Consequently, the proportions of enhancers with evidence of recent selection across 
metrics cannot be directly compared to each other. Distinguishing whether our results are 
best explained by temporal variation in selection or by differences in the power of our 
metrics could be achieved via simulations in which selective events are introduced at 
specific time points and result in a fixed proportion of regions being selected. This is an 
important future research direction that has potential to shed light into the tempo of 
selection in the course of recent human evolution. 
 
An additional result of our study is that the putative target genes of enhancers exhibiting 
significant evidence of recent positive selection according to the nSL metric are enriched 
for immunity-related functions (Tables 4.2-4). Haplotype-based metrics such as nSL are 
known to be sensitive to signatures resulting from selection that occurred approximately 
10,000 - 20,000 years ago, which corresponds to the incidence of the Agricultural 
Revolution (Voight et al. 2006). The advent of farming practices, communal living in 
settlements, and migrations of farmers across the globe resulted in an increase of 
numbers and densities of humans in any given location, likely facilitating the spread of 
pathogens (Varki and Gagneux 2009; Page et al. 2016; Nielsen et al. 2017). In addition, 
recent studies suggest that selection on cis-regulatory regions, such as enhancers, might 
have been important in driving adaptation of modern human populations to distinct 
environments, due to their modular organization: change of expression pattern in one 
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temporal or spatial context can often occur without affecting others, which could 
contribute to phenotypic changes without incurring negative pleiotropic effects (Carroll 
2005; Wray 2007). Therefore, it is possible that around 10,000 - 20,000 years ago, 
enhancers regulating the activities of immunity-related genes underwent selection to 
allow refined fine-tuning of host defense processes in response to the stronger pressure 
from pathogens resulting from increased human population sizes.  
 
Perhaps the most striking result of our study is that brain and testis enhancers exhibited 
different patterns of recent evolution compared to enhancers of other tissues (Figure 4.3 
& Additional Figures 4.4-7). For both brain and testis, the high number of enhancers 
included in these tissues could partly explain our results. Brain, with 4,883 enhancers, 
has the most enhancers of all the tissues examined, while testis, with 1,621 enhancers, 
is ranked 7th. The effect of the large number of enhancers included in these tissues is 
reflected in the differences in the magnitudes of peaks of the distributions of the metrics 
between brain and testis and other tissues (Additional Figures 4.4-7). However, we also 
observed other types of differences in comparisons of the distributions of these metrics 
between brain and testis and other tissues: while subtle, some metrics (Tajima’s D, FST; 
Additional Figures 4.4-5) showed shifts of the distributions of brain and testis enhancers 
towards weaker signatures of recent positive selection compared to other tissues, 
suggesting that the significant pairwise differences we see are not solely caused by 
disparities in the number of enhancers within tissues. In addition, there are several other 
tissues (e.g., lung, spleen, blood) whose numbers of enhancers are nearly on par with 
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those of the brain and more than the testis; however, these tissues did not show 
significant differences in the distribution of these metrics compared to other tissues, 
further suggesting that the observed differences in selection are likely biological.  
 
Why are patterns of selection different for brain and testis enhancers? Answering these 
questions is challenging without additional functional experiments that shed light on the 
phenotypic effects of the selected variants. In the case of the brain, existing evidence 
suggests that the brain size of modern humans has not changed substantially in the last 
250,000 - 300,000 years (Neubauer et al. 2018). Similarly, expression patterns of genes 
expressed in neural tissues (e.g., brain, cerebellum) show low levels of divergence across 
both species and within humans, suggesting that the overall structure of the neural 
network is highly conserved (Khaitovich 2005; Brawand et al. 2011). In contrast, brain 
shape has gradually changed in modern humans, reaching the present-day variation 
human variation about 100,000 - 35,000 years ago, but whether this has anything to do 
with positive selection being relatively weaker in the brain compared to other tissues is 
pure speculation.   
 
In the case of testis, our results suggest that enhancers active in the testis often show 
weaker signatures of positive selection compared to enhancers in other tissues. Previous 
studies have shown that testis exhibits the highest degree of expression pattern 
divergence between species, likely due to either strong action of positive selection on 
reproductive processes (Khaitovich 2005; Brawand et al. 2011), relaxation of purifying 
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selection in the testis compared to other tissues (Gershoni and Pietrokovski 2014), or 
both.  Unfortunately, our results are not directly comparable with studies measuring gene 
expression divergence between species due to the difference in the features being 
compared and the temporal window examined; previous studies have looked at the 
divergence of the overall transcriptome, which is influenced not just by changes in 
enhancer sequences but by other types of changes and other regulatory elements as 
well, whereas we have specifically looked at changes in allele frequency and haplotypes 
in enhancer regions. In addition, previous studies have looked at divergence of the 
expression patterns between species that diverged several millions of years ago, whereas 
we have examined selection events that have occurred in more recent evolutionary times, 
on the order of hundreds or tens of thousands of years. Therefore, it is possible that there 
has been temporal variation (i.e., ancient vs. recent) in the occurrence of selection events 
on these enhancer regions. It is worth noting that Khaitovich et al. (Khaitovich et al. 2005) 
also found that testis had the most significant reductions in diversity of expression (i.e., 
low inter-individual variation in expression patterns) compared to other tissues examined, 
which points to differences in the action of selection over various temporal windows within 
the testis. In short, differences between our results and those of previous studies can be 
explained by differences in actions of ancient versus recent selection.  
 
 
 
 
 
	 142	
Acknowledgments 
This research was supported by the March of Dimes through the March of Dimes 
Prematurity Research Center Ohio Collaborative, the Burroughs Wellcome Fund, the 
Guggenheim Foundation, and the National Institutes of Health (R01GM115836, 
R35GM127087). This work was conducted, in part, using the Advanced Computing 
Center for Research and Education at Vanderbilt University. 
  
	 143	
References 
 
Alexa A, Rahnenfuhrer J. (2016). Gene set enrichment analysis with topGO, R package 
version 2.30.1  
 
Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, Chen Y, Zhao 
X, Schmidl C, Suzuki T, et al. 2014. An atlas of active enhancers across human cell types 
and tissues. Nature 507: 455–461. 
 
Balaresque PL, Ballereau SJ, Jobling MA. 2007. Challenges in human genetic diversity: 
demographic history and adaptation. Human Molecular Genetics 16: R134–R139. 
 
Brawand D, Soumillon M, Necsulea A, Julien P, Csárdi G, Harrigan P, Weier M, Liechti 
A, Aximu-Petri A, Kircher M, et al. 2011. The evolution of gene expression levels in 
mammalian organs. Nature 478: 343–348. 
 
Capra JA, Erwin GD, McKinsey G, Rubenstein JLR, Pollard KS. 2013. Many human 
accelerated regions are developmental enhancers. Philosophical Transactions of the 
Royal Society B: Biological Sciences 368: 20130025–20130025. 
 
Carroll SB. 2005. Evolution at Two Levels: On Genes and Form. PLoS Biol 3: e245. 
Casper J, Zweig AS, Villarreal C, Tyner C, Speir ML, Rosenbloom KR, Raney BJ, Lee 
CM, Lee BT, Karolchik D, et al. 2018. The UCSC Genome Browser database: 2018 
update. Nucleic Acids Research 46: D762–D769. 
 
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. 2015. Second-
generation PLINK: rising to the challenge of larger and richer datasets. GigaSci 4: 559. 
 
Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, 
Lunter G, Marth GT, Sherry ST, et al. 2011. The variant call format and VCFtools. 
Bioinformatics 27: 2156–2158. 
 
Ferrer-Admetlla A, Liang M, Korneliussen T, Nielsen R. 2014. On Detecting Incomplete 
Soft or Hard Selective Sweeps Using Haplotype Structure. Molecular Biology and 
Evolution 31: 1275–1291. 
 
Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau 
A, Hardenbol P, Leal SM, et al. 2007. A second generation human haplotype map of over 
3.1 million SNPs. Nature 449: 851–861. 
 
 
	 144	
Fumagalli M, Sironi M, Pozzoli U, Ferrer-Admettla A, Pattini L, Nielsen R. 2011. 
Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main 
Selective Pressure through Human Evolution ed. J.M. Akey. PLoS Genet 7: e1002355. 
Garud NR, Messer PW, Buzbas EO, Petrov DA. 2015. Recent Selective Sweeps in North 
American Drosophila melanogaster Show Signatures of Soft Sweeps ed. G.P. 
Copenhaver. PLoS Genet 11: e1005004. 
 
Gershoni M, Pietrokovski S. 2017. Reduced selection and accumulation of deleterious 
mutations in genes exclusively expressed in men. Nature Communications 5: 4438. 
 
Gravel S, Henn BM, Gutenkunst RN, Indap AR, Marth GT, Clark AG, Yu F, Gibbs RA, 
1000 Genomes Project, Bustamante CD. 2011. Demographic history and rare allele 
sharing among human populations. Proceedings of the National Academy of Sciences 
108: 11983–11988. 
 
Gu X, Su Z. 2007. Tissue-driven hypothesis of genomic evolution and sequence-
expression correlations. Proc Natl Acad Sci USA 104: 2779–2784. 
 
Haller BC, Messer PW. 2017. SLiM 2: Flexible, Interactive Forward Genetic Simulations. 
Molecular Biology and Evolution 34: 230–240. 
 
Haygood R, Fedrigo O, Hanson B, Yokoyama K-D, Wray GA. 2007. Promoter regions of 
many neural- and nutrition-related genes have experienced positive selection during 
human evolution. Nature Genetics 39: 1140–1144. 
 
Karlsson EK, Kwiatkowski DP, Sabeti PC. 2014. Natural selection and infectious disease 
in human populations. Nature Reviews Genetics 15: 379–393. 
 
Karnuta JM, Scacheri PC. 2018. Enhancers: bridging the gap between gene control and 
human disease. Human Molecular Genetics 27: R219–R227. 
 
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. 
The human genome browser at UCSC. Genome Research 12: 996–1006. 
 
Khaitovich P. 2005. Parallel Patterns of Evolution in the Genomes and Transcriptomes of 
Humans and Chimpanzees. Science 309: 1850–1854. 
 
King MC, Wilson AC. 1975. Evolution at two levels in humans and chimpanzees. Science 
188: 107–116. 
 
Kryuchkova-Mostacci N, Robinson-Rechavi M. 2015. Tissue-Specific Evolution of Protein 
Coding Genes in Human and Mouse ed. M. Anisimova. PLoS ONE 10: e0131673. 
 
	 145	
Kudaravalli S, Veyrieras JB, Stranger BE, Dermitzakis ET, Pritchard JK. 2008. Gene 
Expression Levels Are a Target of Recent Natural Selection in the Human Genome. 
Molecular Biology and Evolution 26: 649–658. 
 
Lee TI, Young RA. 2013. Transcriptional Regulation and Its Misregulation in Disease. Cell 
152: 1237–1251. 
 
Long HK, Prescott SL, Wysocka J. 2016. Ever-Changing Landscapes: Transcriptional 
Enhancers in Development and Evolution. Cell 167: 1170–1187. 
 
Lynch VJ, Nnamani MC, Kapusta A, Brayer K, Plaza SL, Mazur EC, Emera D, Sheikh SZ, 
Grützner F, Bauersachs S, et al. 2015. Ancient Transposable Elements Transformed the 
Uterine Regulatory Landscape and Transcriptome during the Evolution of Mammalian 
Pregnancy. CellReports 10: 551–561. 
 
MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, 
Milano A, Morales J, et al. 2017. The new NHGRI-EBI Catalog of published genome-wide 
association studies (GWAS Catalog). Nucleic Acids Research 45: D896–D901. 
 
Messer PW. 2013. SLiM: Simulating Evolution with Selection and Linkage. Genetics 194: 
1037–1039. 
 
Messer PW, Petrov DA. 2013. Population genomics of rapidadaptation by soft selective 
sweeps. Trends in Ecology & Evolution 1–11. 
 
Moon JM, Aronoff DM, Capra JA, Abbot P, Rokas A. 2018. Examination of Signatures of 
Recent Positive Selection on Genes Involved in Human Sialic Acid Biology. G3 
g3.200035.2018. 
 
Neph S, Kuehn MS, Reynolds AP, Haugen E, Thurman RE, Johnson AK, Rynes E, 
Maurano MT, Vierstra J, Thomas S, et al. 2012. BEDOPS: high-performance genomic 
feature operations. Bioinformatics 28: 1919–1920. 
 
Neubauer S, Hublin J-J, Gunz P. 2018. The evolution of modern human brain shape. Sci 
Adv 4: eaao5961. 
 
Nédélec Y, Sanz J, Baharian G, Szpiech ZA, Pacis A, Dumaine A, Grenier J-C, Freiman 
A, Sams AJ, Hebert S, et al. 2016. Genetic Ancestry and Natural Selection Drive 
Population Differences in Immune Responses to Pathogens. Cell 167: 657–664.e21. 
 
Nielsen R, Akey JM, Jakobsson M, Pritchard JK, Tishkoff S, Willerslev E. Tracing the 
peopling of the world through genomics. Nature 541: 302-310. 
 
	 146	
Ong C-T, Corces VG. 2011. Enhancer function: new insights into the regulation of tissue-
specificgene expression. Nature Reviews Genetics 12: 284–293. 
 
Page AE, Viguier S, Dyble M, Smith D, Chaudhary N, Salali GD, Thompson J, Vinicius L, 
Mace R, Migliano AB. 2016. Reproductive trade-offs in extant hunter-gatherers suggest 
adaptive mechanism for the Neolithic expansion. Proceedings of the National Academy 
of Sciences 113: 4694–4699. 
 
Pennacchio LA, Bickmore W, Dean A, Nobrega MA, Bejerano G. 2013. Enhancers: five 
essential questions. Nature Reviews Genetics 14: 288–295. 
 
Pennings PS, Hermisson J. 2006. Soft Sweeps II—Molecular Population Genetics of 
Adaptation from Recurrent Mutation or Migration. Molecular Biology and Evolution 23: 
1076–1084. 
 
Pfeifer B, Wittelsbürger U, Ramos-Onsins SE, Lercher MJ. 2014. PopGenome: An 
Efficient Swiss Army Knife for Population Genomic Analyses in R. Molecular Biology and 
Evolution 31: 1929–1936. 
 
Raney BJ, Dreszer TR, Barber GP, Clawson H, Fujita PA, Wang T, Nguyen N, Paten B, 
Zweig AS, Karolchik D, et al. 2014. Track data hubs enable visualization of user-defined 
genome-wide annotations on the UCSC Genome Browser. Bioinformatics 30: 1003–
1005. 
 
Rebeiz M, Tsiantis M. 2017. Enhancer evolution and the origins of morphological novelty. 
Current Opinion in Genetics & Development 45: 115–123. 
 
Rockman MV, Hahn MW, Soranzo N, Zimprich F, Goldstein DB, Wray GA. 2005. Ancient 
and Recent Positive Selection Transformed Opioid cis-Regulation in Humans. PLoS Biol 
3: e387. 
 
Rubinstein M, de Souza FSJ. 2013. Evolution of transcriptional enhancers and animal 
diversity. Philosophical Transactions of the Royal Society B: Biological Sciences 368: 
20130017–20130017. 
 
Sabeti, P. C., Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, 
Mikkelsen TS, Altshuler D, Lander ES. 2006. Positive natural selection in the human 
lineage. Science 312: 1614–1620. 
 
Schaffner SF. 2004. The X chromosome in population genetics. Nature Reviews Genetics 
5: 43–51. 
 
Sholtis SJ, Noonan JP. 2010. Gene regulation and the origins of human biological 
uniqueness. Trends in Genetics 26: 110–118. 
	 147	
 
Simonti CN, Pavličev M, Capra JA. 2017. Transposable Element Exaptation into 
Regulatory Regions Is Rare, Influenced by Evolutionary Age, and Subject to Pleiotropic 
Constraints. Molecular Biology and Evolution 34: 2856–2869. 
 
Szpiech ZA, Hernandez RD. 2014. selscan: An Efficient Multithreaded Program to 
Perform EHH-Based Scans for Positive Selection. Molecular Biology and Evolution 31: 
2824–2827. 
 
The 1000 Genomes Project Consortium, Gibbs RA, Boerwinkle E, Doddapaneni H, Han 
Y, Korchina V, Kovar C, Lee S, Muzny D, Reid JG, et al. 2015. A global reference for 
human genetic variation. Nature 526: 68–74. 
 
The FANTOM Consortium and the RIKEN PMI and CLST (DGT). 2014. A promoter-level 
mammalian expression atlas. Nature 507: 462–470. 
 
Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, Powell K, 
Mortensen HM, Hirbo JB, Osman M, et al. 2006. Convergent adaptation of human lactase 
persistence in Africa and Europe. Nature Genetics 39: 31–40. 
 
Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson 
A, Kampf C, Sjostedt E, Asplund A, et al. 2015. Tissue-based map of the human 
proteome. Science 347: 1260419–1260419. 
 
Varki A, Gagneux P. 2009. Human-specific evolution of sialic acid targets: Explaining the 
malignant malaria mystery? Proc Natl Acad Sci USA 106: 14739. 
 
Vitti JJ, Grossman SR, Sabeti PC. 2013. Detecting Natural Selection in Genomic Data. 
Annu Rev Genet 47: 97–120. 
 
Voight BF, Kudaravalli S, Wen X, Pritchard JK. 2006. A Map of Recent Positive Selection 
in the Human Genome ed. L. Hurst. PLoS Biol 4: e72. 
 
Wang JZ, Du Z, Payattakool R, Yu PS, Chen CF. 2007. A new method to measure the 
semantic similarity of GO terms. Bioinformatics 23: 1274–1281. 
 
Wray GA. 2007. The evolutionary significance of cis-regulatory mutations. Nature 
Reviews Genetics 8: 206–216. 
 
Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S. 2010. GOSemSim: an R package for measuring 
semantic similarity among GO terms and gene products. Bioinformatics 26: 976–978. 
 
  
	 148	
CHAPTER V 
 
Conclusion 
 
Recent evolution of sialic acid biology genes in modern humans 
 
In Chapter III, I examined the patterns of recent evolution of a set of genes that are 
involved in sialic acid biology. I used several metrics that are sensitive to distinct types of 
genomic signatures resulting from recent positive selection. In addition, I carried out 
simulations of neutral evolution that incorporated pre-estimated parameters of past 
demographic events to assess the probability that the observed metrics resulted from 
actions of selection. In short, I showed that the majority of sialic acid biology genes do not 
exhibit evidence of recent positive selection across all time ranges examined. 
Furthermore, even when I calculated H12, a novel metric shown to exhibit increased 
sensitivity towards incidences of soft selective sweeps (Garud et al. 2015), the majority 
of the genes did not show significant deviations from neutral expectations.  
 
It has been widely hypothesized that the sialic acid biology pathway has evolved via rapid 
evolution due to strong selective pressures from pathogens (Varki 2002; Angata and Varki 
2002; Varki and Gagneux 2009; Hayakawa and Varki 2011; Wang et al. 2012) and 
previous work has focused on ancient selection events (Altheide et al. 2006) and found 
evidence of positive selection in response to paleopathogens. The contrasting results of 
my study with the prevailing hypothesis and past findings suggest the action of temporally 
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varying (i.e., ancient versus recent) selection on the pathway of sialic acid biology: more 
specifically, it is possible that sialic acid biology genes experienced adaptation in 
response to ancient but not more recent pathogens. More broadly, my study shows that 
the same gene (or set of genes) could experience temporally varying selection events 
and emphasize that selective pressures are not necessarily consistent across time.  
 
Despite the overall lack of significant evidence of recent positive selection in sialic acid 
biology genes, this approach could still serve as a first step towards understanding the 
evolution of genetic elements that are associated with human pregnancy. Given the 
importance of refined regulation of the maternal immune system during pregnancy, it is 
possible that the patterns of recent evolution of immunity-related genes reflect the action 
of pregnancy-related selective pressures as well. In this regard, a recent study identified 
a set of changes in immune system that occur over the course of a term pregnancy 
(Aghaeepour et al. 2017): these include endogenous pSTAT5ab signaling in naive CD4+ 
T cells, pSTAT5ab response to IL in neutrophils, and pSTAT1 response to IFN-a in NK 
cells. Genes involved in these immune system alternations could serve as potential 
candidates for studies of recent positive selection of genetic elements associated with 
pregnancy.  
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Recent evolution of enhancers across 41 human tissues 
In Chapter IV, I studied the recent evolution of enhancers active in 41 human tissues, 
which include reproductive tissues such as placenta, female gonad, and testis, as well as 
somatic tissues such as brain, heart, and liver. As in Chapter III, I used several metrics 
that can detect distinct genomic signatures of recent positive selection. These metrics 
were then compared to those calculated on sequences created by simulations of neutral 
evolution that incorporated pre-estimated parameters of past demographic events to 
determine the likelihood of recent positive selection. First, I found that on average, 
approximately 5.90% of enhancers exhibit evidence of significant recent positive selection 
across all metrics and tissues. Second, I found that the putative target genes of enhancers 
with significant deviations from neutral expectations according to the nSL metric exhibit 
enrichment for immunity-related functions. In addition, this pattern of functional 
enrichment was shared across tissues, and thus represents a more global trend. Next, I 
found that the patterns of recent evolution differed between enhancers active in brain and 
testis and several other tissues: while this difference could be due to non-adaptive 
processes (as majority of the enhancers exhibit non-significant deviations from neutral 
expectations), one possibility is differential actions of positive selection on enhancers 
active in the brain and testis and other tissues. 
 
One possible explanation for the enrichment for immunity functions among putative target 
genes of enhancers showing evidence of recent positive selection according to nSL is the 
incidence of the Agricultural Revolution, which occurred approximately 10,000 to 20,000 
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years ago. During this period, the advent of farming practices, communal living in 
settlements, and migrations of farmers across the globe resulted in an increase of 
numbers and densities of humans in any given location, likely facilitating the spread of 
pathogens (Varki and Gagneux 2009; Pool et al. 2010; Nielsen et al.). Such an increase 
in pathogen burden would have likely acted as a strong selective pressure on immunity 
genes, as well as their cis-regulatory regions. Another selective pressure that could have 
acted simultaneously on these enhancers is the need to regulate immune responses 
during pregnancy to prevent inappropriate and excessive activation of detrimental 
immune responses. Therefore, it is possible that around 10,000 - 20,000 years ago, 
enhancers regulating the activities of immunity-related genes underwent selection to 
allow refined fine-tuning of immune activities to enable effective host defenses against 
the increased threat from pathogens resulting from increased human population sizes as 
well as, establishment and maintenance of successful pregnancy.  
 
As more research suggests the importance of cis-regulatory regions in driving local 
adaptations of modern humans (Wray 2007; Nédélec et al. 2016) to different 
environments, enhancers could be incorporated into future studies of recent evolution of 
genetic elements involved in human pregnancy. For instance, a recent study successfully 
predicted a large number of placental enhancers using a machine learning approach 
(Zhang et al. 2018): these enhancers were likely to be near genes associated with 
placental development and birth disorders, validating their roles in human pregnancy. 
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Finally, additional functional information of enhancers - for instance, the gestational 
period at which such enhancers are active  - could provide additional interesting insights. 
 
Future direction: the need for quantitative assessment of the relative contributions 
of various selective pressures  
I have described in Chapter II how various population genetics metrics can be used to 
infer past selection events that occurred in recent human history. In addition, programs 
that can execute sophisticated simulations of neutral evolution by incorporating pre-
estimated demographic parameters can greatly reduce false positives. However, the 
metric of selection by itself cannot provide information regarding the specific selective 
pressures that have acted on the region of interest: the metric summarizes the 
simultaneous actions of multiple evolutionary forces, including neutral and random 
processes as well as several selective forces. Furthermore, significant deviation from 
neutral expectations indicates that the region of interest has likely experienced selection, 
but again, cannot identify the exact causative selective agent. In this regard, one caution 
in interpreting the results of my studies in Chapters III and IV is not to definitively conclude 
that the patterns of genetic variation have resulted from selective pressures associated 
with pregnancy, host defenses, or any single selective pressure. 
 
In this regard, a previous study calculated the relative contributions of various 
environmental variables related to climatic and dietary factors, as well as pathogen loads 
within each population to the allele frequency spectrum of variants and determined that 
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once corrected for demography, pathogen accounted for most of the genetic variance 
among populations (Fumagalli et al. 2011).  However, quantifying the relative contribution 
of selection pressures associated with reproductive processes on the observed patterns 
of genetic variation is even more challenging, especially because of 1) the uncertainty 
associated with defining pregnancy as an environmental variable and 2) the lack of in-
depth phenotypic data that spans multiple populations. Specific aspects of pregnancy 
(e.g., average birth weight, gestational length, incidences of pregnancy disorders within 
a population) could serve as proxies for selective pressures that pregnancy imposes on 
genetic regions of interest within modern humans. As in Fumagali and his colleagues’ 
work (Fumagalli et al. 2011), these variables could be incorporated into the matrix of 
environmental variables to calculate the relative contribution of selective pressures 
associated with pregnancy to the observed metrics of recent selection.  
 
Summary 
Collectively, my dissertation research has investigated the patterns of recent evolution of 
genetic elements involved in pregnancy within modern humans. More specifically, I tested 
the hypothesis that sialic acid biology genes (Chapter III) and enhancers expressed in 
different tissues (Chapter IV) have experienced recent positive selection in modern 
humans. My studies show the utility of incorporating different metrics that can capture 
distinct genomic signatures resulting from selection events that occurred at different time 
ranges (and under different modes of selection), allowing a more comprehensive 
investigation of the action of recent selection in a region of interest (Chapter II). The 
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discovery of new genes or pathways that are associated with term pregnancy and 
pregnancy disorders (Aghaeepour et al. 2017; Zhang et al. 2017) could provide 
interesting candidate regions for future studies. In addition, new metrics with increased 
sensitivity to novel genomic signatures could detect selection events that have been 
previously been missed due to lack of power (Field et al. 2016). Finally, quantitatively 
comparing the relative contributions of selective pressures stemming from host defense 
and pregnancy could shed light into how trade-offs between immunity and reproduction 
have shaped the patterns of genetic variation in modern humans. 
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APPENDIX 
 
All additional files are available at https://figshare.com/s/241fb6cd6b6be6a2ec9a 
 
